Document:

SECURITIES PURCHASE AGREEMENT

      SECURITIES  PURCHASE AGREEMENT (the  "AGREEMENT"),  dated as of August 20,
2004, by and among Dendo Global Corp., a Nevada  corporation,  with headquarters
located at 3311 N. Kennicott Ave., Suite A, Arlington Heights,  IL. 60004 (to be
renamed TechAlt, Inc.) (the "COMPANY"), and the investors listed on the Schedule
of Buyers  attached  hereto  (individually,  a  "BUYER"  and  collectively,  the
"BUYERS").

      WHEREAS:

      A. The Company has authorized a new series of convertible preferred shares
of the Company, the terms of which are set forth in the Company's Certificate of
Designation  (the  "CERTIFICATE")  in the form  attached  hereto  as  EXHIBIT  A
(together with any convertible preferred shares issued in replacement thereof in
accordance  with the terms thereof,  the "PREFERRED  SHARES"),  which  Preferred
Shares shall be convertible into shares of the Company's Common Stock, par value
$.001  per  share  (the  "COMMON  STOCK")  in  accordance  with the terms of the
Certificate.

      B. Each Buyer wishes to purchase, and the Company wishes to sell, upon the
terms and conditions  stated in this  Agreement,  (i) that  aggregate  number of
Preferred  Shares  set forth  opposite  such  Buyer's  name in column (3) on the
Schedule  of Buyers  (which  aggregate  number for all  Buyers  shall be 500,000
Preferred Shares) which are convertible into Common Stock in accordance with the
Certificate (as converted,  collectively, the "INITIAL CONVERSION SHARES"), (ii)
warrants,  in substantially  the form attached hereto as EXHIBIT B (the "INITIAL
Warrants"),  to acquire that number of shares of Common Stock set forth opposite
such  Buyer's  name in  column  (4) on the  Schedule  of Buyers  (as  exercised,
collectively,  the "INITIAL WARRANT SHARES"), (iii) a right in substantially the
form  attached  hereto as  EXHIBIT C (the  "ADDITIONAL  INVESTMENT  RIGHTS")  to
acquire all the Preferred  Shares (as exercised,  collectively,  the "ADDITIONAL
INVESTMENT  RIGHT  SHARES") set forth  opposite  such Buyer's name in column (5)
(which  aggregate  number for all Buyers shall be 3,500,000  Preferred  Shares),
which  shall be  convertible  into  shares of Common  Stock (as  converted,  the
"ADDITIONAL CONVERSION SHARES," and together with the Initial Conversion Shares,
the  CONVERSION  SHARES"),  and (iv)  that  number  of  additional  warrants  in
substantially the form attached hereto as EXHIBIT D, (the "ADDITIONAL  WARRANTS"
and together with the Initial  Warrants,  the "WARRANTS") to acquire that number
of shares of Common  Stock set forth  opposite  such  Buyer's name in column (6)
(the  "ADDITIONAL  WARRANT SHARES" and together with the Initial Warrant Shares,
the "WARRANT SHARES").

      C. The Company and each Buyer is executing and  delivering  this Agreement
in reliance upon the exemption from securities  registration afforded by Section
4(2) of the Securities Act of 1933, as amended (the "1933 ACT"), and Rule 506 of
Regulation D ("REGULATION D") as promulgated by the United States Securities and
Exchange  Commission  (the "SEC") under the 1933 Act to the extent  necessary to
issue the Preferred Shares,  the Conversion Shares, the Warrants and the Warrant
Shares.

<PAGE>

      D.  Contemporaneously  with the execution and delivery of this  Agreement,
the parties hereto are executing and delivering a Registration Rights Agreement,
substantially in the form attached hereto as EXHIBIT E (the "REGISTRATION RIGHTS
AGREEMENT"),  pursuant  to which  the  Company  has  agreed to  provide  certain
registration  rights with respect to the  Registrable  Securities (as defined in
the  Registration  Rights  Agreement)  under  the  1933  Act and the  rules  and
regulations promulgated thereunder, and applicable state securities laws.

      E. The Preferred Shares, the Additional  Investment Rights, the Additional
Investment  Right Shares,  the Conversion  Shares,  the Warrants and the Warrant
Shares collectively are referred to herein as the "SECURITIES".

      NOW, THEREFORE, the Company and each Buyer hereby agree as follows:

      1.  PURCHASE  AND  SALE  OF  PREFERRED  SHARES,  WARRANTS  AND  ADDITIONAL
INVESTMENT RIGHTS.

            (a) PURCHASE OF PREFERRED SHARES, WARRANTS AND ADDITIONAL INVESTMENT
RIGHTS.

                  (i)  PREFERRED  SHARES,  WARRANTS  AND  ADDITIONAL  INVESTMENT
RIGHTS.  Subject to the  satisfaction (or waiver) of the conditions set forth in
Sections 6 and 7 below, the Company shall issue and sell to each Buyer, and each
Buyer  severally,  but not jointly,  agrees to purchase  from the Company on the
Closing Date (as defined below),  the number of Preferred Shares as is set forth
opposite  such Buyer's name in column (3) on the Schedule of Buyers,  along with
Initial  Warrants  to acquire  that number of Initial  Warrant  Shares set forth
opposite  such Buyer's name in column (4) on the Schedule of Buyers,  along with
the  Additional  Investment  Rights to acquire up to that  number of  Additional
Investment  Right Shares set forth  opposite  such Buyer's name in column (5) on
the  Schedule  of Buyers  and  Additional  Warrants  to acquire  that  number of
Additional  Warrant  Shares  in  Column  (6)  on the  Schedule  of  Buyers  (the
"CLOSING").

                  (ii)  CLOSING.  The Closing shall occur on the Closing Date at
the offices of Schulte Roth & Zabel LLP, 919 Third  Avenue,  New York,  New York
10022.

                  (iii) PURCHASE  PRICE.  The purchase price for each Buyer (the
"PURCHASE  PRICE")  of  the  Preferred  Shares,   the  Warrants  and  Additional
Investment  Rights to be  purchased  by each such Buyer at the Closing  shall be
equal to $1.00 for each  Preferred  Share and related  Warrants,  and Additional
Investment Right being purchased by such Buyer at the Closing.

            (b) CLOSING  DATE.  The date and time of the Closing  (the  "CLOSING
DATE") shall be 10:00 a.m.,  New York City Time,  on the date of this  Agreement
after  notification of satisfaction (or waiver) of the conditions to the Closing
set forth in Sections 6 and 7 below (or such later date as is mutually agreed to
by the Company and each Buyer).

<PAGE>

            (c) FORM OF PAYMENT.  On the Closing Date,  (i) each Buyer shall pay
its Purchase Price to the Company for the Preferred Shares, the Warrants and the
Additional Investment Rights to be issued and sold to such Buyer at the Closing,
by wire transfer of immediately available funds in accordance with the Company's
written wire instructions,  and (ii) the Company shall deliver to each Buyer the
Preferred  Shares (in the  denominations as such Buyer shall request) which such
Buyer is then  purchasing  hereunder  along  with the  corresponding  amount  of
Warrants  and  Additional  Investment  Rights  such  Buyer is  purchasing,  duly
executed on behalf of the Company  and  registered  in the name of such Buyer or
its designee.

      2. BUYER'S  REPRESENTATIONS  AND  WARRANTIES.  Each Buyer  represents  and
warrants with respect to only itself that:

            (a) NO PUBLIC SALE OR DISTRIBUTION.  Such Buyer is (i) acquiring the
Preferred Shares, the Warrants and the Additional  Investment Rights;  (ii) upon
conversion  of the  Preferred  Shares and exercise of the  Warrants  (other than
pursuant to Cashless  Exercise (as defined in the  Warrants)) and the Additional
Investment  Rights and upon  payment of any  Dividend  Shares (as defined in the
Certificate), will acquire the Conversion Shares issuable upon conversion of the
Preferred  Shares,  any such Dividend  Shares,  the Warrant Shares issuable upon
exercise of the Warrants and the  Additional  Investment  Right Shares  issuable
upon exercise of the Additional  Investment Rights; and (iii) upon conversion of
the Additional  Investment  Right Shares will acquire the Additional  Conversion
Shares  issuable upon conversion of the Additional  Investment  Right Shares for
its own account and not with a view towards,  or for resale in connection  with,
the public sale or distribution thereof,  except pursuant to sales registered or
exempted   under  the  1933  Act;   PROVIDED,   HOWEVER,   that  by  making  the
representations  herein, such Buyer does not agree to hold any of the Securities
for any minimum or other  specific term and reserves the right to dispose of the
Securities  at any  time  in  accordance  with  or  pursuant  to a  registration
statement  or an  exemption  under the 1933 Act.  Such  Buyer is  acquiring  the
Securities  hereunder  in the  ordinary  course  of  its  business.  Such  Buyer
presently does not have any agreement or understanding,  directly or indirectly,
with  any  Person  (as  defined  in  Section  3(r))  to  distribute  any  of the
Securities.

            (b)  ACCREDITED  INVESTOR  STATUS.  Such  Buyer  is  an  "accredited
investor" as that term is defined in Rule 501(a) of Regulation D.

            (c)  RELIANCE  ON  EXEMPTIONS.   Such  Buyer  understands  that  the
Securities  are being offered and sold to it in reliance on specific  exemptions
from the registration requirements of United States federal and state securities
laws and that the Company is relying in part upon the truth and accuracy of, and
such Buyer's  compliance  with,  the  representations,  warranties,  agreements,
acknowledgments  and  understandings  of such Buyer set forth herein in order to
determine the  availability of such exemptions and the eligibility of such Buyer
to acquire the Securities.

            (d)  INFORMATION.  Such Buyer and its  advisors,  if any,  have been
furnished with all materials  relating to the business,  finances and operations
of the Company and  materials  relating to the offer and sale of the  Securities
which have been  requested by such Buyer.  Such Buyer and its advisors,  if any,
have been afforded the opportunity to ask questions of the Company. Neither such
inquiries nor any other due diligence  investigations conducted by such Buyer or
its advisors,  if any, or its representatives shall modify, amend or affect such
Buyer's right to rely on the Company's  representations and warranties contained
herein.

<PAGE>

            (e)  NO  GOVERNMENTAL   REVIEW.   Such  Buyer  understands  that  no
Governmental  Authority  (as defined in Section  3(v)) has passed on or made any
recommendation  or  endorsement of the Securities or the fairness or suitability
of the  investment in the Securities  nor have such  authorities  passed upon or
endorsed the merits of the offering of the Securities.

            (f)  TRANSFER  OR RESALE.  Such  Buyer  understands  that  except as
provided in the Registration Rights Agreement:  (i) the Securities have not been
and are not being  registered  under the 1933 Act or any state  securities laws,
and may not be  offered  for sale,  sold,  assigned  or  transferred  unless (A)
subsequently  registered thereunder,  (B) such Buyer shall have delivered to the
Company an opinion of counsel, in a form reasonably satisfactory to the Company,
to the effect that such  Securities to be sold,  assigned or transferred  may be
sold,  assigned or transferred  pursuant to an exemption from such registration,
or (C)  such  Buyer  shall  have  satisfied  the  requirements  of  Rule  144(k)
promulgated  under the 1933 Act, as amended (or a successor rule thereto);  (ii)
any sale of the Securities made in reliance on Rule 144 or Rule 144A promulgated
under the 1933 Act,  as amended  (or a successor  rule  thereto)  (collectively,
"RULE  144"),  may be made  only in  accordance  with the  terms of Rule 144 and
further,  if Rule 144 is not  applicable,  any  resale of the  Securities  under
circumstances  in which the seller (or the Person through whom the sale is made)
may be deemed to be an underwriter (as that term is defined in the 1933 Act) may
require compliance with some other exemption under the 1933 Act or the rules and
regulations of the SEC  thereunder;  and (iii) neither the Company nor any other
Person is under any obligation to register the Securities  under the 1933 Act or
any state  securities  laws or to comply  with the terms and  conditions  of any
exemption  thereunder.  The Securities may be pledged in connection  with a bona
fide margin  account or other loan secured by the  Securities and such pledge of
Securities  shall not be  deemed to be a  transfer,  sale or  assignment  of the
Securities  hereunder,  and no Buyer  effecting a pledge of Securities  shall be
required to provide the Company with any notice  thereof or  otherwise  make any
delivery to the  Company  pursuant to this  Agreement  or any other  Transaction
Document,  including,  without limitation,  this Section 2(f); PROVIDED, that in
order to make any sale, transfer or assignment of Securities, such Buyer and its
pledgee makes such  disposition in accordance with or pursuant to a registration
statement or an exemption under the 1933 Act.

            (g) LEGENDS.  Such Buyer  understands that the certificates or other
instruments representing the Preferred Shares,  Warrants,  Additional Investment
Rights and the  Additional  Investment  Right Shares and, until such time as the
resale of  Registrable  Securities  have been  registered  under the 1933 Act as
contemplated  by the  Registration  Rights  Agreement,  the  stock  certificates
representing the Registrable  Securities,  except as set forth below, shall bear
any legend as  required  by the "blue  sky" laws of any state and a  restrictive
legend in  substantially  the following form (and a  stop-transfer  order may be
placed against transfer of such stock certificates):

<PAGE>

            [NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS
            CERTIFICATE  NOR THE  SECURITIES  INTO WHICH  THESE  SECURITIES  ARE
            [CONVERTIBLE]  [EXERCISABLE]  HAVE BEEN] [THE SHARES  REPRESENTED BY
            THIS  CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT
            OF 1933, AS AMENDED. NO SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT
            AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF
            COUNSEL IN A FORM  REASONABLY  SATISFACTORY TO THE COMPANY THAT SUCH
            REGISTRATION  IS NOT REQUIRED  UNDER THE  SECURITIES ACT OF 1933, AS
            AMENDED,   OR  UNLESS  SOLD  PURSUANT  TO  RULE  144  OF  SUCH  ACT.
            NOTWITHSTANDING  THE  FOREGOING,  THE  SECURITIES  MAY BE PLEDGED IN
            CONNECTION  WITH A  BONA  FIDE  MARGIN  ACCOUNT  OR  OTHER  LOAN  OR
            FINANCING ARRANGEMENT SECURED BY THE SECURITIES.

The legend  set forth  above  shall be removed  and the  Company  shall  issue a
certificate without such legend to the holder of the Securities upon which it is
stamped,  if,  unless  otherwise  required by state  securities  laws,  (i) such
Securities are registered for resale under the 1933 Act, (ii) in connection with
a sale,  assignment or other transfer,  such holder provides the Company with an
opinion of counsel,  in a form  reasonably  acceptable  to the  Company,  to the
effect that such sale,  assignment  or transfer  of the  Securities  may be made
without  registration  under the 1933 Act,  or (iii) such  holder  provides  the
Company with reasonable  assurance that the Securities can be sold,  assigned or
transferred pursuant to Rule 144.

            (h) ORGANIZATION;  AUTHORIZATION;  VALIDITY; ENFORCEMENT. Such Buyer
is validly  existing and in good standing under the laws of the  jurisdiction of
its  organization,  and has the requisite power and authorization to execute and
deliver this Agreement and the  Registration  Rights Agreement and to consummate
the  transaction  contemplated  hereby  and  thereby.  This  Agreement  and  the
Registration  Rights Agreement have been duly and validly  authorized,  executed
and  delivered  on behalf of such  Buyer and  constitute  the  legal,  valid and
binding  obligations of such Buyer enforceable  against such Buyer in accordance
with their respective  terms,  except as such  enforceability  may be limited by
general   principles  of  equity  or  to  applicable   bankruptcy,   insolvency,
reorganization,  moratorium,  liquidation and other similar laws relating to, or
affecting  generally,  the  enforcement  of  applicable  creditors'  rights  and
remedies.

            (i)  RESIDENCY.  Such Buyer is a resident  of that  country or state
specified below its address on the Schedule of Buyers.

            (j)  Acknowledgment  Regarding Buyer's Purchase of Securities.  Such
Buyer is acting solely in the capacity of arm's length purchaser with respect to
the Transaction Documents and the transactions  contemplated hereby and thereby,
and such Buyer is not an officer or director of the Company. Further, such Buyer
is not acting as a  financial  advisor or  fiduciary  of the  Company (or in any
similar capacity) with respect to the Transaction Documents and the transactions
contemplated  hereby and thereby.  Such Buyer  acknowledges  and agrees that the
Company  has not made any  representations  or  warranties  with  respect to the
transactions  contemplated  hereby  other than those  specifically  set forth in
Section 3.

<PAGE>

      3.  REPRESENTATIONS AND WARRANTIES OF THE COMPANY.  The Company represents
and warrants to each of the Buyers that:

            (a)   ORGANIZATION   AND   QUALIFICATION.   The   Company   and  its
"SUBSIDIARIES"  (which for purposes of this Agreement  means any entity in which
the Company,  directly or  indirectly,  owns capital stock or holds a comparable
equity or similar  interest) are entities duly organized and validly existing in
good standing (to the extent  applicable)  under the laws of the jurisdiction in
which they are  organized,  and have the requisite  corporate or other power and
authorization  to own their  properties  and to carry on their  business  as now
being conducted. Each of the Company and its Subsidiaries is duly qualified as a
foreign entity to do business and is in good standing (to the extent applicable)
in every  jurisdiction  in which its  ownership of property or the nature of the
business  conducted  by it makes  such  qualification  necessary,  except to the
extent  that the failure to be so  qualified  or be in good  standing  could not
reasonably  be  expected  to have a  Material  Adverse  Effect.  As used in this
Agreement,  "MATERIAL  ADVERSE EFFECT" means any material  adverse effect on the
business,  properties,  assets,  operations,  results of  operations,  condition
(financial or otherwise) or prospects of the Company and its Subsidiaries, taken
as a whole, or on the transactions contemplated hereby and the other Transaction
Documents (as defined below) or by the agreements and  instruments to be entered
into in connection  herewith or therewith,  including the Intellectual  Property
License  Agreement  (as herein  defined) or on the  authority  or ability of the
Company to perform its obligations under the Transaction  Documents or under the
Intellectual Property License Agreement.  The Company has no Subsidiaries except
as set forth on SCHEDULE 3(A).

            (b)  AUTHORIZATION;  ENFORCEMENT;  VALIDITY.  The  Company  has  the
requisite   corporate  power  and  authority  to  enter  into  and  perform  its
obligations  under this Agreement,  the  Certificate,  the  Registration  Rights
Agreement,  the Irrevocable  Transfer Agent  Instructions (as defined in Section
5(b)),  the Warrants,  the  Additional  Investment  Rights and each of the other
agreements and documents  entered into by the parties hereto in connection  with
the transactions contemplated by this Agreement (collectively,  the "TRANSACTION
DOCUMENTS")  and to issue the Securities in accordance with the terms hereof and
thereof. The execution and delivery of the Transaction  Documents by the Company
and the consummation by the Company of the transactions  contemplated hereby and
thereby,  including,  without limitation,  the issuance of the Preferred Shares,
the Warrants,  and the  Additional  Investment  Rights and the  reservation  for
issuance and the issuance of the  Conversion  Shares,  the Warrant  Shares,  and
Additional Investment Right Shares issuable upon conversion or exercise thereof,
the  reservation  for issuance and the issuance of the Dividend  Shares issuable
thereon, as the case may be, have been duly authorized by the Company's Board of
Directors and no further  consent or  authorization  is required by the Company,
its  Board of  Directors  or its  stockholders.  This  Agreement  and the  other
Transaction  Documents have been duly executed and delivered by the Company, and
constitute the legal, valid and binding  obligations of the Company  enforceable
against the Company in accordance with their  respective  terms,  except as such
enforceability  may be  limited by general  principles  of equity or  applicable
bankruptcy, insolvency, reorganization,  moratorium, liquidation or similar laws
relating to, or affecting  generally,  the enforcement of applicable  creditors'
rights and remedies.  As of the Closing,  the Certificate of Designations in the
form attached as EXHIBIT A shall have been filed on or prior to the Closing Date
with the  Secretary  of State of the State of Nevada  and shall be in full force
and effect, enforceable against the Company in with its terms and shall not have
been amended.

<PAGE>

            (c) ISSUANCE OF SECURITIES.  The Preferred Shares,  the Warrants and
Additional   Investment  Rights  are  duly  authorized  and,  upon  issuance  in
accordance with the terms hereof,  shall be validly issued, free from all taxes,
liens and charges with respect to the issue  thereof,  and the Preferred  Shares
shall be entitled to the rights and preferences as set forth in the Certificate.
As of the  Closing,  a number of shares of  Common  Stock  shall  have been duly
authorized  and reserved for issuance which equals 130% of the maximum number of
shares of Common Stock  issuable upon  conversion  of the  Preferred  Shares and
Additional  Investment Right Shares, as the case may be, and 130% of the maximum
number of shares of Common Stock  issuable  upon  exercise of the Warrants to be
issued  at the  Closing  and 100% of the  maximum  number  of  Preferred  Shares
issuable upon, the exercise of the Additional Investment Rights. Upon conversion
or  exercise  in  accordance  with the  Preferred  Shares,  the  Warrants or the
Additional  Investment  Rights,  as the case may be,  and upon  issuance  of the
Dividend Shares as dividends on the Preferred  Shares and Additional  Investment
Right Shares, the Conversion Shares, the Warrant Shares and the Dividend Shares,
respectively, will be validly issued, fully paid and nonassessable and free from
all taxes, liens and charges with respect to the issue thereof, with the holders
being entitled to all rights accorded to a holder of Common Stock.  Assuming the
accuracy of each of the  representations  and  warranties of Buyer  contained in
Section  2, the  issuance  by the  Company  of the  Securities  is  exempt  from
registration under the 1933 Act.

            (d) NO CONFLICTS.  The  execution,  delivery and  performance of the
Transaction  Documents by the Company and the consummation by the Company of the
transactions contemplated hereby and thereby (including, without limitation, the
issuance of the Preferred Shares, Warrants, and Additional Investment Rights and
reservation  for issuance and issuance of the  Conversion  Shares,  the Dividend
Shares and the Warrant Shares and the Additional  Investment  Right Shares) will
not (i) result in a violation of the articles of incorporation,  any certificate
of designations,  preferences and rights of any outstanding  series of preferred
stock or bylaws  of the  Company  or any  Subsidiary,  (ii)  conflict  with,  or
constitute  a default  (or an event  which with  notice or lapse of time or both
would  become a default)  under,  or give to others  any rights of  termination,
amendment, acceleration or cancellation of, any material agreement, indenture or
instrument to which the Company or any of its  Subsidiaries is a party, or (iii)
result in a violation of any law, rule,  regulation,  order,  judgment or decree
(including  federal and state  securities laws and regulations and the rules and
regulations of the OTC Bulletin Board or an Eligible  Market)  applicable to the
Company  or any of its  Subsidiaries  or by which any  property  or asset of the
Company or any of its  Subsidiaries  is bound or affected.  For purposes of this
Agreement,  "ELIGIBLE MARKET" means any of the American Stock Exchange,  The New
York Stock Exchange, the Nasdaq National Market or The Nasdaq SmallCap Market.

            (e) CONSENTS.  All  consents,  authorizations,  orders,  filings and
registrations  which the Company is required as of the Closing Date to obtain to
execute,  deliver or perform any of its obligations under or contemplated by the
Transaction  Documents in accordance with their terms will have been obtained or
effected on or prior to the Closing Date. The Company and its  Subsidiaries  are
unaware of any facts or  circumstances  which  might  reasonably  be expected to
prevent the Company from obtaining or effecting any of the foregoing.

<PAGE>

            (f)  ACKNOWLEDGMENT  REGARDING  BUYER'S PURCHASE OF SECURITIES.  The
Company acknowledges and agrees that each Buyer is acting solely in the capacity
of arm's length  purchaser  with respect to the  Transaction  Documents  and the
transactions contemplated hereby and thereby, and that no Buyer is an officer or
director of the  Company.  The  Company  further  acknowledges  that no Buyer is
acting as a  financial  advisor or  fiduciary  of the Company (or in any similar
capacity)  with  respect  to the  Transaction  Documents  and  the  transactions
contemplated  hereby and thereby,  and any advice given by a Buyer or any of its
representatives  or agents in connection with the Transaction  Documents and the
transactions  contemplated  hereby  and  thereby  is merely  incidental  to such
Buyer's purchase of the Securities. The Company further represents to each Buyer
that the  Company's  decision to enter into the  Transaction  Documents has been
based   solely  on  the   independent   evaluation   by  the   Company  and  its
representatives.

            (g) NO GENERAL  SOLICITATION;  PLACEMENT  AGENT'S FEES.  Neither the
Company,  nor any of its  affiliates,  nor any  Person  acting  on its or  their
behalf, has engaged in any form of general  solicitation or general  advertising
(within the meaning of Regulation D) in connection with the offer or sale of the
Securities.  The Company shall be  responsible  for the payment of any placement
agent's fees,  financial advisory fees, or brokers'  commissions (other than for
persons engaged by any Buyer or its investment  advisor)  relating to or arising
out of the  transactions  contemplated  hereby.  The Company shall pay, and hold
each Buyer harmless against, any liability, loss or expense (including,  without
limitation,  attorney's fees and  out-of-pocket  expenses) arising in connection
with any such  claim.  The  Company  acknowledges  that it has  engaged  Sunrise
Securities  Corporation as placement  agent (the "AGENT") in connection with the
sale of the Preferred Shares,  Warrants and Additional  Investment Rights. Other
than the Agent,  the Company has not engaged any placement  agent or other agent
in connection  with the sale of the Preferred  Shares,  Warrants and  Additional
Investment Rights.

            (h) NO INTEGRATED  OFFERING.  None of the Company, its Subsidiaries,
any of their affiliates,  and any Person acting on their behalf has, directly or
indirectly,  made any offers or sales of any security or solicited any offers to
buy any security,  under circumstances that would require registration of any of
the Securities under the 1933 Act or cause this offering of the Securities to be
integrated  with prior  offerings by the Company for purposes of the 1933 Act or
any applicable stockholder approval provisions,  including,  without limitation,
under the rules and regulations of any exchange or automated quotation system on
which any of the securities of the Company are listed or designated. None of the
Company,  its  Subsidiaries,  their  affiliates  and any Person  acting on their
behalf will take any action or steps referred to in the preceding  sentence that
would require  registration of any of the Securities under the 1933 Act or cause
the offering of the Securities to be integrated with other offerings.

            (i) DILUTIVE EFFECT. The Company further  acknowledges that, subject
to the terms and  conditions of the  Transaction  Documents,  its  obligation to
issue  Conversion  Shares upon conversion of the Preferred  Shares in accordance
with this  Agreement  and the  Preferred  Shares,  its  obligation  to issue the
Warrant  Shares upon exercise of the Warrants in accordance  with this Agreement
and the Warrants, its obligation to issue the Additional Investment Right Shares
upon  exercise  of the  Additional  Investment  Rights in  accordance  with this
Agreement and the Additional  Investment  Rights is, in each case,  absolute and
unconditional  regardless of the dilutive  effect that such issuance may have on
the ownership interests of other stockholders of the Company.

<PAGE>

            (j)  APPLICATION  OF TAKEOVER  PROTECTIONS;  RIGHTS  AGREEMENT.  The
Company and its board of directors have taken all necessary  action,  if any, in
order  to  render   inapplicable   any  control  share   acquisition,   business
combination,  poison pill (including any distribution  under a rights agreement)
or other similar anti-takeover provision under the Articles of Incorporation (as
defined in Section 3(q)) or the laws of the state of its incorporation  which is
or  could  become  applicable  to any  Buyer  as a  result  of the  transactions
contemplated by this Agreement,  including,  without  limitation,  the Company's
issuance of the  Securities  and any Buyer's  ownership of the  Securities.  The
Company  has not  adopted  a  stockholder  rights  plan or  similar  arrangement
relating to accumulations of beneficial ownership of Common Stock or a change in
control of the Company.

            (k) SEC DOCUMENTS;  FINANCIAL STATEMENTS.  The Company has filed all
reports,  schedules,  forms, statements and other documents required to be filed
by it with the SEC  pursuant to the  reporting  requirements  of the  Securities
Exchange Act of 1934,  as amended (the "1934 ACT") (all of the  foregoing  filed
prior to the date hereof,  or in connection  with the Closing  subsequent to the
date hereof,  filed prior to the date of the Closing,  and all exhibits included
therein  and  financial   statements   and   schedules   thereto  and  documents
incorporated  by reference  therein  being  hereinafter  referred to as the "SEC
DOCUMENTS").  The  Company  has  delivered  to the  Buyers  or their  respective
representatives  true,  correct and  complete  copies of the SEC  Documents  not
available on the EDGAR system.  As of their respective  dates, the SEC Documents
complied in all material  respects with the requirements of the 1934 Act and the
rules and  regulations of the SEC promulgated  thereunder  applicable to the SEC
Documents,  and none of the SEC Documents,  at the time they were filed with the
SEC,  contained  any untrue  statement of a material  fact or omitted to state a
material  fact  required to be stated  therein or necessary in order to make the
statements  therein,  in the light of the  circumstances  under  which they were
made, not misleading.  As of their respective dates, the financial statements of
the Company  included in the SEC  Documents  complied as to form in all material
respects with  applicable  accounting  requirements  and the published rules and
regulations of the SEC with respect thereto. Such financial statements have been
prepared  in  accordance   with  generally   accepted   accounting   principles,
consistently  applied,  during  the  periods  involved  (except  (i)  as  may be
otherwise  indicated in such financial  statements or the notes thereto, or (ii)
in the case of  unaudited  interim  statements,  to the extent  they may exclude
footnotes or may be condensed or summary  statements)  and fairly present in all
material respects the financial  position of the Company as of the dates thereof
and the  results of its  operations  and cash flows for the  periods  then ended
(subject,  in the  case  of  unaudited  statements,  to  normal  year-end  audit
adjustments).  No other  information  provided by or on behalf of the Company to
the  Buyers  which is not  included  in the SEC  Documents  contains  any untrue
statement of a material  fact or omits to state any material  fact  necessary in
order to make the statements  therein,  in the light of the  circumstance  under
which they are or were made and, taken together with the  information  set forth
in the SEC Documents, not misleading.

<PAGE>

            (l)  ABSENCE OF CERTAIN  CHANGES.  Except as  disclosed  in SCHEDULE
3(L),  since December 31, 2003, there has been no material adverse change and no
material adverse development in the business, properties,  operations, condition
(financial or  otherwise),  results of operations or prospects of the Company or
its  Subsidiaries.  Since December 31, 2003, the Company has not (i) declared or
paid any dividends,  (ii) sold any assets,  individually or in the aggregate, in
excess of  $100,000  outside of the  ordinary  course of  business  or (iii) had
capital expenditures,  individually or in the aggregate,  in excess of $100,000.
The  Company  has not  taken  any  steps  to  seek  protection  pursuant  to any
bankruptcy law nor does the Company have any knowledge or reason to believe that
its  creditors  intend to initiate  involuntary  bankruptcy  proceedings  or any
actual  knowledge of any fact which would  reasonably  lead a creditor to do so.
The  Company  is not as of the date  hereof,  and  after  giving  effect  to the
transactions  contemplated hereby to occur at the Closing, will not be Insolvent
(as defined below). For purposes of this Section 3(l), "INSOLVENT" means (i) the
present  fair  saleable  value of the  Company's  assets is less than the amount
required to pay the Company's total indebtedness,  contingent or otherwise, (ii)
the Company is unable to pay its debts and liabilities, subordinated, contingent
or otherwise,  as such debts and liabilities become absolute and matured,  (iii)
the Company  intends to incur or believes that it will incur debts that would be
beyond  its  ability  to pay as such  debts  mature  or  (iv)  the  Company  has
unreasonably  small  capital  with which to conduct the  business in which it is
engaged as such business is now conducted and is proposed to be conducted.

            (m)   NO   UNDISCLOSED   EVENTS,   LIABILITIES,    DEVELOPMENTS   OR
CIRCUMSTANCES. No event, liability,  development or circumstance has occurred or
exists,  or is  contemplated  to  occur,  with  respect  to the  Company  or its
Subsidiaries or their respective business, properties,  prospects, operations or
financial condition, that would be required to be disclosed by the Company under
applicable  securities  laws on a registration  statement on Form S-1 filed with
the SEC  relating to an issuance and sale by the Company of its Common Stock and
which has not been publicly announced.

<PAGE>

            (n) CONDUCT OF BUSINESS; REGULATORY PERMITS. Neither the Company nor
its Subsidiaries is in violation of any term of or in default under its Articles
of  Incorporation,  any  Certificate,  Preferences and Rights of any outstanding
series of  preferred  stock of the  Company  or  Bylaws or their  organizational
charter or bylaws,  respectively (except, with respect to the Subsidiaries,  for
violations  that could not,  individually  or in the  aggregate,  reasonably  be
expected to have a Material Adverse Effect).  Neither the Company nor any of its
Subsidiaries  is in violation of any  judgment,  decree or order or any statute,
ordinance, rule or regulation applicable to the Company or its Subsidiaries, and
neither the Company nor any of its  Subsidiaries  will  conduct its  business in
violation of any of the foregoing,  except for possible  violations  which could
not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect. Without limiting the generality of the foregoing, the Company is
not in violation of any of the listing requirements of the OTC Bulletin Board or
an Eligible  Market and has no  knowledge  of any facts or  circumstances  which
would  reasonably lead to delisting or suspension of the Common Stock by the OTC
Bulletin Board or an Eligible Market, as applicable,  in the foreseeable future.
The Common Stock has been designated for quotation or listed on the OTC Bulletin
Board or an  Eligible  Market,  (ii)  trading in the  Common  Stock has not been
suspended by the SEC, the OTC Bulletin  Board or such Eligible  Market and (iii)
the Company has received no  communication,  written or oral,  from the SEC, the
OTC Bulletin Board or an Eligible  Market  regarding the suspension or delisting
of the Common  Stock from the OTC Bulletin  Board or such  Eligible  Market,  as
applicable.  The Company and its Subsidiaries possess all Governmental Approvals
issued by the appropriate  Governmental Authorities (as defined in Section 3(v))
necessary to conduct their  respective  businesses,  except where the failure to
possess such  Governmental  Approvals  could not reasonably be expected to have,
individually or in the aggregate,  a Material  Adverse  Effect,  and neither the
Company nor any such Subsidiary has received any notice of proceedings  relating
to the revocation or modification of any such Governmental Approval.

            (o) FOREIGN CORRUPT PRACTICES.  Neither the Company,  nor any of its
Subsidiaries,  nor any director, officer, agent, employee or other Person acting
on behalf of the  Company or any of its  Subsidiaries  has, in the course of its
actions for, or on behalf of, the Company (i) used any  corporate  funds for any
unlawful contribution,  gift,  entertainment or other unlawful expenses relating
to political activity;  (ii) made any direct or indirect unlawful payment to any
foreign or domestic  government official or employee from corporate funds; (iii)
violated  or is in  violation  of any  provision  of the  U.S.  Foreign  Corrupt
Practices  Act of 1977,  as amended;  or (iv) made any unlawful  bribe,  rebate,
payoff, influence payment,  kickback or other unlawful payment to any foreign or
domestic government official or employee.

            (p) TRANSACTIONS WITH AFFILIATES. None of the officers, directors or
employees  of the  Company  is  presently  a party to any  transaction  with the
Company or any of its  Subsidiaries  (other than for ordinary course services as
employees,  officers or directors),  including any contract,  agreement or other
arrangement  providing for the  furnishing  of services to or by,  providing for
rental of real or personal property to or from, or otherwise  requiring payments
to or from any such  officer,  director or employee or, to the  knowledge of the
Company, any corporation,  partnership,  trust or other entity in which any such
officer,  director,  or employee  has a  substantial  interest or is an officer,
director, trustee or partner.

<PAGE>

            (q) EQUITY  CAPITALIZATION.  As of the date hereof,  the  authorized
capital stock of the Company consists of (x) 50,000,000  shares of Common Stock,
of which as of the date hereof,  12,000,000 are issued and outstanding  (none of
which are treasury  shares),  5,000,000  shares of common stock are reserved for
issuance  pursuant  to the  Company's  2004 Stock  Option  Plan (the "2004 Stock
Option  Plan") and no shares are reserved for  issuance  pursuant to  securities
(other than the aforementioned options, the Preferred Shares discussed below and
the Warrants)  exercisable or exchangeable  for, or convertible  into, shares of
Common Stock,  and (y) 5,000,000  shares of preferred  stock par value $.001 per
share, of which none are issued and  outstanding.  As used herein,  the "Company
2004 Stock  Option  Plan"  shall mean the  Company's  2004  Stock  Option  Plan.
SCHEDULE 3(Q) contains a complete and accurate list of the record and beneficial
owners of all of the Company's  outstanding  securities  and options to purchase
securities and the names and amounts of any securities to be issued prior to the
nine-month  anniversary  of the date hereof  pursuant  to the 2004 Stock  Option
Plan.  All of such  outstanding  shares  have been,  or upon  issuance  will be,
validly  issued  and are fully  paid and  nonassessable.  Except as set forth on
SCHEDULE  3(Q) there are no  outstanding  convertible  or  non-convertible  debt
securities,  notes,  credit  agreements,  credit facilities or other agreements,
documents or instruments evidencing Indebtedness (as defined in Section 3(r)) of
the  Company or any of its  Subsidiaries  or by which the  Company or any of its
Subsidiaries  is or may become bound.  Except as set forth on Schedule 3(q): (i)
no shares of the Company's capital stock are subject to preemptive rights or any
other similar rights or any liens or  encumbrances  suffered or permitted by the
Company;  (ii) there are no  outstanding  options,  warrants,  scrip,  rights to
subscribe to, calls or commitments of any character  whatsoever  relating to, or
securities or rights  convertible  into, or exercisable or exchangeable for, any
shares of capital stock of the Company or any of its Subsidiaries, or contracts,
commitments,  understandings  or arrangements by which the Company or any of its
Subsidiaries is or may become bound to issue additional  shares of capital stock
of the Company or any of its Subsidiaries or options, warrants, scrip, rights to
subscribe to, calls or commitments of any character  whatsoever  relating to, or
securities or rights  convertible  into, or exercisable or exchangeable for, any
shares of capital stock of the Company or any of its  Subsidiaries;  (iii) there
are no financing statements securing obligations in any material amounts, either
singly or in the aggregate, filed in connection with the Company; (iv) there are
no agreements or arrangements under which the Company or any of its Subsidiaries
is obligated to register the sale of any of their  securities under the 1933 Act
(except  the  Registration  Rights  Agreement);  (v)  there  are no  outstanding
securities  or  instruments  of the  Company  or any of its  Subsidiaries  which
contain  any  redemption  or  similar  provisions,  and there are no  contracts,
commitments,  understandings  or arrangements by which the Company or any of its
Subsidiaries  is or may become  bound to redeem a security of the Company or any
of its  Subsidiaries;  (vi) there are no  securities or  instruments  containing
anti-dilution,  pre-emptive or similar  provisions that will be triggered by the
issuance  of  the  Securities;  (vii)  the  Company  does  not  have  any  stock
appreciation  rights or "phantom  stock" plans or agreements or any similar plan
or agreement; and (viii) the Company and its Subsidiaries have no liabilities or
obligations  required to be disclosed in the SEC Documents  (as defined  herein)
but not so  disclosed  in the SEC  Documents,  other than those  incurred in the
ordinary course of the Company's or its Subsidiaries'  respective businesses and
which,  individually  or in the  aggregate,  do not or could not  reasonably  be
expected to have a Material  Adverse  Effect.  The Company has made available to
the Buyer  true,  correct  and  complete  copies of the  Company's  Articles  of
Incorporation, as amended and as in effect on the date hereof (together with any
certificate of designations of any outstanding  series of preferred stock of the
Company, the "ARTICLES OF INCORPORATION"),  and the Company's Bylaws, as amended
and as in  effect  on the  date  hereof  (the  "BYLAWS"),  and the  terms of all
securities  convertible  into, or exercisable or exchangeable  for, Common Stock
and the material rights of the holders thereof in respect thereto.

<PAGE>

            (r) INDEBTEDNESS AND OTHER CONTRACTS. Neither the Company nor any of
its Subsidiaries (i) has any outstanding  Indebtedness (as defined below),  (ii)
is a party to any contract,  agreement or instrument, the violation of which, or
default  under which,  by the other  party(ies) to such  contract,  agreement or
instrument  could reasonably be expected to result in a Material Adverse Effect,
(iii) is in violation of any term of or in default under any contract, agreement
or instrument  relating to any  Indebtedness,  except where such  violations and
defaults  could not  reasonably  be expected to result,  individually  or in the
aggregate,  in a Material  Adverse  Effect,  or (iv) is a party to any contract,
agreement or instrument relating to any Indebtedness,  the performance of which,
in the judgment of the Company's officers, has or is expected to have a Material
Adverse Effect. For purposes of this Agreement: (x) "INDEBTEDNESS" of any Person
means,  without  duplication (A) all  indebtedness  for borrowed money,  (B) all
obligations  issued,  undertaken  or assumed as the deferred  purchase  price of
property or services  (other than trade  payables  entered  into in the ordinary
course of business),  (C) all reimbursement or payment  obligations with respect
to  letters of  credit,  surety  bonds and other  similar  instruments,  (D) all
obligations  evidenced  by notes,  bonds,  debentures  or  similar  instruments,
including  obligations so evidenced  incurred in connection with the acquisition
of property, assets or businesses, (E) all indebtedness created or arising under
any  conditional  sale or  other  title  retention  agreement,  or  incurred  as
financing,  in either case with respect to any property or assets  acquired with
the  proceeds of such  indebtedness  (even though the rights and remedies of the
seller or bank  under such  agreement  in the event of  default  are  limited to
repossession or sale of such property),  (F) all monetary  obligations under any
leasing or similar  arrangement  which,  in connection  with generally  accepted
accounting principles,  consistently applied for the periods covered thereby, is
classified as a capital lease, (G) all  indebtedness  referred to in clauses (A)
through (F) above secured by (or for which the holder of such  Indebtedness  has
an existing  right,  contingent  or  otherwise,  to be secured by) any mortgage,
lien,  pledge,  charge,  security interest or other encumbrance (each, a "LIEN")
upon or in any property or assets (including accounts and contract rights) owned
by any Person, even though the Person which owns such assets or property has not
assumed or become  liable  for the  payment  of such  indebtedness,  and (H) all
Contingent  Obligations in respect of  indebtedness  or obligations of others of
the kinds  referred  to in  clauses  (A)  through  (G)  above;  (y)  "CONTINGENT
OBLIGATION"  means,  as  to  any  Person,  any  direct  or  indirect  liability,
contingent or otherwise, of that Person with respect to any indebtedness, lease,
dividend or other  obligation of another Person if the primary purpose or intent
of the Person  incurring such liability,  or the primary effect  thereof,  is to
provide  assurance to the obligee of such  liability that such liability will be
paid or  discharged,  or that any agreements  relating  thereto will be complied
with,  or that the holders of such  liability  will be protected (in whole or in
part) against loss with respect thereto; and (z) "PERSON" means an individual, a
limited liability  company,  a partnership,  a joint venture,  a corporation,  a
trust,  an  unincorporated  organization  and a government or any  department or
agency thereof.

<PAGE>

            (s) ABSENCE OF  LITIGATION.  There is no action,  suit,  proceeding,
inquiry or investigation, whether criminal, civil or otherwise, before or by the
Nasdaq Stock Market,  the OTC Bulletin Board or an Eligible  Market,  any court,
public  board,  Governmental  Authority,  self-regulatory  organization  or body
pending or, to the knowledge of the Company, threatened against or affecting the
Company,  the Common Stock or any of the  Company's  Subsidiaries  or any of the
Company's  or  the  Company's  Subsidiaries'  officers  or  directors  in  their
capacities as such,  except (i) as disclosed in Item 3 of the  Company's  Annual
Report on Form 10-KSB for the year ended  December  31, 2003 or (ii) such as are
not reasonably be expected to have, individually or in the aggregate, a Material
Adverse  Effect.  To the  knowledge  of the  Company,  none of the  directors or
officers of the Company have been a party to any securities  related  litigation
during the past five years, other than as disclosed in the SEC Documents.

            (t) INSURANCE.  The Company and each of its Subsidiaries are insured
by insurers of recognized financial responsibility against such losses and risks
and in such  amounts as  management  of the  Company  believes to be prudent and
customary  in the  businesses  in which the  Company  and its  Subsidiaries  are
engaged.  Neither  the  Company  nor any such  Subsidiary  has been  refused any
insurance  coverage  sought or applied  for and neither the Company nor any such
Subsidiary  has any  reason  to  believe  that it will not be able to renew  its
existing  insurance  coverage  as and when such  coverage  expires  or to obtain
similar  coverage  from  similar  insurers as may be  necessary  to continue its
business at a cost that could not have a Material Adverse Effect.

            (u)  EMPLOYEE  RELATIONS.   Neither  the  Company  nor  any  of  its
Subsidiaries  is a party to any collective  bargaining  agreement or employs any
member of a union. The Company and its Subsidiaries believe that their relations
with their  employees are good. No executive  officer of the Company (as defined
in Rule  501(f) of the 1933 Act) has  notified  the  Company  that such  officer
intends to leave the Company or otherwise  terminate such  officer's  employment
with the Company.  No executive officer of the Company,  to the knowledge of the
Company,  is, or is now expected to be, in violation of any material term of any
employment  contract,  confidentiality,  disclosure or  proprietary  information
agreement,  non-competition agreement, or any other contract or agreement or any
restrictive  covenant,  and, to the  knowledge  of the  Company,  the  continued
employment of each such executive officer does not subject the Company or any of
its Subsidiaries to any material  liability with respect to any of the foregoing
matters.  The Company and its  Subsidiaries  are in compliance with all federal,
state,  local  and  foreign  laws  and  regulations  respecting  employment  and
employment  practices,  terms and  conditions of employment and wages and hours,
except where failure to be in compliance  could not,  either  individually or in
the aggregate, reasonably be expected to result in a Material Adverse Effect.

<PAGE>

            (v) TITLE. The Company and its Subsidiaries have good and marketable
title to all personal  property  owned by them which is material to the business
of the Company and its  Subsidiaries,  in each case free and clear of all liens,
encumbrances  and  defects  except  (i)  immaterial  liens  for  taxes  not  yet
delinquent,  (ii)  immaterial  mechanics'  and  materialmen's  liens  (and other
similar liens), and immaterial liens under operating and similar agreements,  to
the  extent the same  relate to  expenses  incurred  in the  ordinary  course of
business  and  that  are  not yet  due,  (iii)  that  are  routine  Governmental
Approvals,  or (iv) such as do not materially  affect the value of such property
and do not interfere  with the use made and proposed to be made of such property
by the Company and any of its  Subsidiaries.  Upon execution of the Intellectual
Property  License  Agreement  by the parties  thereto,  the Company  will have a
license to use all intellectual property which is material to the conduct of the
business of Technology Alternatives,  Inc., as currently conducted, in each case
free and clear of all liens,  encumbrances  and  defects  except (i)  immaterial
liens for taxes not yet delinquent, (ii) immaterial mechanics' and materialmen's
liens (and other  similar  liens),  and  immaterial  liens under  operating  and
similar  agreements,  to the extent the same relate to expenses  incurred in the
ordinary  course of  business  and that are not yet due,  (iii) that are routine
Governmental  Approvals,  or (iv) such as do not materially  affect the value of
such  property  or  the  Intellectual  Property  License  Agreement  and  do not
interfere  with the use made and  proposed  to be made of such  property  or the
Intellectual   Property  License  Agreement  by  the  Company  and  any  of  its
Subsidiaries.  Neither  the Company  nor any of its  Subsidiaries  owns any real
property.  Any real property and facilities  held under lease by the Company and
any of its Subsidiaries are held by them under valid, subsisting and enforceable
leases with such  exceptions as are not material and do not  interfere  with the
use made and proposed to be made of such  property and  buildings by the Company
and  its  Subsidiaries.  For  purposes  of  this  Agreement:  (a)  "GOVERNMENTAL
APPROVAL"  means  any  authorization,  approval,  consent,  franchise,  license,
covenant, order, ruling, permit,  certification,  exemption, notice, declaration
or similar  right,  undertaking  or other  action  of, to or by, or any  filing,
qualification  or  registration  with,  any  Governmental  Authority;   and  (b)
"GOVERNMENTAL  AUTHORITY" means any nation or government,  any state,  province,
city,  municipal  entity  or  other  political   subdivision  thereof,  and  any
governmental,  executive,  legislative,  judicial,  administrative or regulatory
agency, department,  authority,  instrumentality,  commission,  board or similar
body, whether federal, state, provincial, territorial, local or foreign.

<PAGE>

            (w) INTELLECTUAL PROPERTY RIGHTS. Upon execution of the Intellectual
Property  License  Agreement  by  the  parties  thereto,  the  Company  and  its
Subsidiaries  will  own or  possess  adequate  rights  or  licenses  to use  all
trademarks,  trade names,  service marks,  service mark  registrations,  service
names, patents,  patent rights,  copyrights,  inventions,  licenses,  approvals,
Governmental  Approvals,  trade secrets and other  intellectual  property rights
("INTELLECTUAL   PROPERTY   RIGHTS")   necessary  to  conduct  their  respective
businesses and the business of Technology  Alternatives,  Inc. as now conducted.
None of the Company's  Intellectual  Property Rights have expired or terminated,
or are  expected to expire or  terminate  within two years from the date of this
Agreement,  except for those  which  could not  reasonably  be expected to have,
individually or in the aggregate,  a Material  Adverse Effect.  The Company does
not have any knowledge of any infringement by the Company or its Subsidiaries of
Intellectual  Property Rights of others. There is no claim, action or proceeding
being made or brought,  or to the  knowledge of the Company,  being  threatened,
against the Company or its  Subsidiaries  regarding  its  Intellectual  Property
Rights.  The Company does not have any  knowledge of any facts or  circumstances
which might give rise to any of the foregoing  infringements or claims,  actions
or proceedings.  The Company and its Subsidiaries have taken reasonable security
measures  to  protect  the  secrecy,  confidentiality  and value of all of their
intellectual properties.

            (x) ENVIRONMENTAL  LAWS. The Company and its Subsidiaries (i) are in
compliance with any and all Environmental  Laws (as hereinafter  defined),  (ii)
have received all permits,  licenses or other  approvals  required of them under
applicable  Environmental Laws to conduct their respective  businesses and (iii)
are in compliance  with all terms and conditions of any such permit,  license or
approval  where,  in each of the  foregoing  clauses  (i),  (ii) and (iii),  the
failure to so comply could be reasonably  expected to have,  individually  or in
the aggregate,  a Material Adverse Effect. The term  "ENVIRONMENTAL  LAWS" means
all federal, state, local or foreign laws relating to pollution or protection of
human health or the environment  (including,  without  limitation,  ambient air,
surface  water,  groundwater,  land surface or  subsurface  strata),  including,
without  limitation,  laws  relating  to  emissions,   discharges,  releases  or
threatened  releases  of  chemicals,  pollutants,   contaminants,  or  toxic  or
hazardous substances or wastes  (collectively,  "HAZARDOUS  MATERIALS") into the
environment, or otherwise relating to the manufacture, processing, distribution,
use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all  authorizations,  codes,  decrees,  demands  or  demand  letters,
injunctions,  judgments,  licenses,  notices or notice letters, orders, permits,
plans or regulations issued, entered, promulgated or approved thereunder.

            (y) SUBSIDIARY  RIGHTS.  The Company or one of its  Subsidiaries has
the  unrestricted  right  to  vote,  and  (subject  to  limitations  imposed  by
applicable  law)  to  receive   dividends  and  distributions  on,  all  capital
securities  of its  material  Subsidiaries  as  owned  by the  Company  or  such
Subsidiary.

            (z) TAX STATUS.  The Company  and each of its  Subsidiaries  (i) has
made or filed all federal and state  income and all other tax  returns,  reports
and declarations  required by any jurisdiction to which it is subject,  (ii) has
paid all taxes and other governmental  assessments and charges that are material
in  amount,  shown  or  determined  to be  due  on  such  returns,  reports  and
declarations, except those being contested in good faith and (iii) has set aside
on its books  provision  reasonably  adequate  for the  payment of all taxes for
periods subsequent to the periods to which such returns, reports or declarations
apply. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company know of no
basis for any such claim.

<PAGE>

            (aa)  INTERNAL  ACCOUNTING  CONTROLS.  The  Company  and each of its
Subsidiaries  maintain a system of internal  accounting  controls  sufficient to
provide  reasonable  assurance that (i)  transactions are executed in accordance
with  management's  general or specific  authorizations,  (ii)  transactions are
recorded  as  necessary  to  permit  preparation  of  financial   statements  in
conformity with generally accepted  accounting  principles and to maintain asset
and  liability   accountability,   (iii)  access  to  assets  or  incurrence  of
liabilities  is  permitted  only in  accordance  with  management's  general  or
specific  authorization  and (iv) the  recorded  accountability  for  assets and
liabilities is compared with the existing  assets and  liabilities at reasonable
intervals and appropriate  action is taken with respect to any  difference.  The
Company maintains disclosure controls and procedures (as such term is defined in
Rule 13a-14 under the 1934 Act) that are effective in ensuring that  information
required to be  disclosed by the Company in the reports that it files or submits
under the 1934 Act is recorded,  processed,  summarized and reported, within the
time  periods  specified in the rules and forms of the SEC,  including,  without
limitation,  controls  and  procedures  designed in to ensure  that  information
required to be  disclosed by the Company in the reports that it files or submits
under the 1934 Act is accumulated and communicated to the Company's  management,
including  its  principal  executive  officer  or  officers  and  its  principal
financial  officer  or  officers,  as  appropriate,  to allow  timely  decisions
regarding required disclosure.

            (bb)  SARBANES-OXLEY  ACT. The Company is in compliance with any and
all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective
as of the  date  hereof,  and any  and  all  applicable  rules  and  regulations
promulgated  by the SEC  thereunder  that are  effective  as of the date hereof,
except where such noncompliance could not have a Material Adverse Effect.

            (cc)  INVESTMENT  COMPANY  STATUS.  The  Company  is not,  and  upon
consummation of the sale of the Securities will not be, an "investment company,"
a company controlled by an "investment company" or an "affiliated person" of, or
"promoter" or "principal underwriter" for, an "investment company" as such terms
are defined in the Investment Company Act of 1940, as amended.

            (dd) FORM SB-2 ELIGIBILITY.  The Company is eligible to register the
Securities  for  resale by the  Buyers  using  Form SB-2  promulgated  under the
Securities Act of 1933, as amended.

            (ee) DISCLOSURE.  The Company confirms that neither it nor any other
Person  acting on its behalf has  provided  any of the Buyers or their agents or
counsel with any  information  that  constitutes or might  constitute  material,
nonpublic  information.  The Company  understands  and confirms that each of the
Buyers will rely on the foregoing  representations in effecting  transactions in
securities of the Company.  All disclosure  provided to the Buyers regarding the
Company, its business and the transactions  contemplated  hereby,  including the
Schedules to this Agreement, furnished by or on behalf of the Company taken as a
whole is true and correct and do not contain any untrue  statement of a material
fact  or omit to  state  any  material  fact  necessary  in  order  to make  the
statements made therein, in the light of the circumstances under which they were
made,  not  misleading.  No event or  circumstance  has occurred or  information
exists with  respect to the Company or any of its  Subsidiaries  or its or their
business,  properties,  prospects,  operations or financial  conditions,  which,
under  applicable  law,  rule  or  regulation,  requires  public  disclosure  or
announcement  by the  Company but which has not been so  publicly  announced  or
disclosed.  The Company  acknowledges and agrees that no Buyer makes or has made
any representations or warranties with respect to the transactions  contemplated
hereby other than those specifically set forth in Section 2.

<PAGE>

      4. COVENANTS.

            (a) BEST  EFFORTS.  Each party shall use its best efforts  timely to
satisfy each of the  conditions  to be satisfied by it as provided in Sections 6
and 7 of this Agreement.

            (b) FORM D AND BLUE SKY.  The  Company  agrees to file a Form D with
respect to the Securities as required  under  Regulation D and to provide a copy
thereof to each Buyer  promptly  after such  filing.  The Company  shall,  on or
before the  Closing  Date,  take such  action as the  Company  shall  reasonably
determine is  necessary  in order to obtain an  exemption  for or to qualify the
Securities  for sale to the Buyers at the  Closing  pursuant  to this  Agreement
under  applicable  securities  or "Blue  Sky" laws of the  states of the  United
States (or to obtain an exemption  from such  qualification),  and shall provide
evidence  of any such  action so taken to the Buyers on or prior to the  Closing
Date.  The Company shall make all filings and reports  relating to the offer and
sale of the Securities  required under applicable  securities or "Blue Sky" laws
of the states of the United States following the Closing Date.

            (c)  REPORTING  STATUS.  Until the date on which the  Investors  (as
defined in the Registration Rights Agreement) shall have sold all the Conversion
Shares  and  Warrant  Shares  and  none of the  Preferred  Shares,  Warrants  or
Additional  Investment  Rights is  outstanding,  (the "REPORTING  PERIOD"),  the
Company shall file all reports required to be filed with the SEC pursuant to the
1934 Act, and the Company shall not  terminate its status as an issuer  required
to file  reports  under  the 1934 Act  even if the  1934  Act or the  rules  and
regulations thereunder would otherwise permit such termination.

            (d) USE OF PROCEEDS. The Company will use the proceeds from the sale
of the Securities for working capital  purposes and not for the repayment of any
outstanding Indebtedness of the Company or any of its Subsidiaries or redemption
or repurchase of any of its equity securities.

            (e) FINANCIAL INFORMATION.  The Company agrees to send the following
to each Investor during the Reporting  Period (i) unless the following are filed
with the SEC through  EDGAR and are  available  to the public  through the EDGAR
system,  within one (1)  Business  Day after the filing  thereof with the SEC, a
copy of its Annual Reports on Form 10-K or 10-KSB, as applicable,  its Quarterly
Reports on Form 10-Q or 10-QSB,  as applicable,  any Current Reports on Form 8-K
and any  registration  statements or amendments  filed pursuant to the 1933 Act,
(ii) on the same day as the  release  thereof,  facsimile  copies  of all  press
releases issued by the Company or any of its  Subsidiaries,  and (iii) copies of
any notices and other information made available or given to the stockholders of
the Company  generally,  contemporaneously  with the making  available or giving
thereof to the stockholders.  As used herein, "BUSINESS DAY" means any day other
than Saturday,  Sunday or other day on which commercial banks in The City of New
York are authorized or required by law to remain closed.

<PAGE>

            (f) LISTING. The Company shall promptly secure the listing of all of
the Registrable  Securities (as defined in the  Registration  Rights  Agreement)
upon each national  securities  exchange and automated quotation system, if any,
upon which shares of Common Stock are then listed (subject to official notice of
issuance) and shall maintain,  so long as any other shares of Common Stock shall
be so listed,  such  listing  of all  Registrable  Securities  from time to time
issuable  under  the  terms of the  Transaction  Documents.  The  Company  shall
maintain  the Common  Stock's  authorization  for  quotation on the OTC Bulletin
Board or an Eligible  Market.  Neither  the Company nor any of its  Subsidiaries
shall  take any  action  which  could be  reasonably  expected  to result in the
delisting or  suspension  of the Common Stock on the OTC Bulletin  Board or such
Eligible Market.  The Company shall pay all fees and expenses in connection with
satisfying its obligations under this Section 4(f).

            (g) FEES. At the Closing,  the Company  shall pay a maximum  expense
allowance  of  $39,500  for legal  fees to  Smithfield  Fiduciary  LLC (a Buyer)
("SMITHFIELD") or its designee(s),  which amount shall be withheld by such Buyer
from its Purchase Price at the Closing. The Company shall be responsible for the
payment of any placement  agent's  fees,  financial  advisory  fees, or broker's
commissions relating to or arising out of the transactions  contemplated hereby,
including, without limitation, any fees or commissions payable to the Agent. The
Company shall pay, and hold each Buyer harmless against, any liability,  loss or
expense  (including,   without  limitation,   reasonable   attorney's  fees  and
out-of-pocket  expenses)  arising in connection  with claim relating to any such
payment.  Except as otherwise set forth in this Agreement or in the Registration
Rights  Agreement,  each party to this Agreement  shall bear its own expenses in
connection  with the sale of the  Securities to the Buyers.  Upon the additional
closing of the  Additional  Investment  Right,  the Company  shall pay a maximum
expense   allowance  of  $10,000  for  the  legal  fees  to  Smithfield  or  its
designee(s),  which  amount  shall be withheld  by such Buyer from its  Purchase
Price at the additional closing of the Additional Investment Right.

            (h) PLEDGE OF SECURITIES.  The Company  acknowledges and agrees that
the  Securities  may be pledged by an Investor  (as defined in the  Registration
Rights  Agreement) in connection with a bona fide margin agreement or other loan
or financing  arrangement that is secured by such Securities.  The pledge of the
Securities  shall not be  deemed to be a  transfer,  sale or  assignment  of the
Securities hereunder,  and no Investor effecting a pledge of Securities shall be
required to provide the Company with any notice  thereof or  otherwise  make any
delivery to the  Company  pursuant to this  Agreement  or any other  Transaction
Document,  including,  without  limitation,  Section  2(f)  of  this  Agreement;
provided  that an Investor and its pledgee  shall be required to comply with the
provisions  of  Section  2(f)  hereof  in order to  effect a sale,  transfer  or
assignment of Securities to such pledgee.  The Company  hereby agrees to execute
and deliver such documentation as a pledgee of Securities may reasonably request
in connection  with a pledge of such  Securities to such pledgee by an Investor.
If any of the Securities are pledged, such Buyer and its pledgee shall make such
disposition  in accordance  with or pursuant to a  registration  statement or an
exemption under the 1933 Act.

<PAGE>

            (i) DISCLOSURE OF TRANSACTIONS AND OTHER MATERIAL INFORMATION. On or
before  8:30 a.m.,  New York City Time,  on the second  Business  Day  following
execution of this Agreement, the Company shall file a Current Report on Form 8-K
describing  the  terms  of the  transactions  contemplated  by  the  Transaction
Documents  in the form  required by the 1934 Act,  and  attaching  the  material
Transaction  Documents  (including,  without  limitation,  this  Agreement,  the
Registration  Rights  Agreement,  the  Certificate  and the form of  Warrant) as
exhibits to such filing (including all attachments,  the "8-K FILING"). From and
after the filing of the 8-K Filing with the SEC, no Buyer shall be in possession
of any material,  nonpublic  information  in regards to the Company,  any of its
Subsidiaries or any of its respective officers, directors,  employees or agents,
that is not disclosed in the 8-K Filing.  The Company shall not, and shall cause
each of its  Subsidiaries  and  its  and  each  of  their  respective  officers,
directors,  employees  and agents,  not to,  provide any Buyer with any material
nonpublic  information regarding the Company or any of its Subsidiaries from and
after the filing of the 8-K Filing  with the SEC  without  the  express  written
consent of such Buyer. In the event of a breach of the foregoing covenant by the
Company,  any of its  Subsidiaries,  any of its or  their  respective  officers,
directors,  employees and agents, or any of the Buyers, in addition to any other
remedy provided herein or in the Transaction  Documents,  a Buyer shall have the
right  to make a  public  disclosure,  in the  form of a press  release,  public
advertisement or otherwise,  of such material nonpublic  information;  provided,
however,  that such Buyer shall give the Company  notice of the  information  it
plans to  disclose  prior to any  disclosure  thereof.  No Buyer  shall have any
liability to the Company,  its  Subsidiaries,  or any of its or their respective
officers, directors, employees,  stockholders or agents for any such disclosure.
Subject to the  foregoing,  neither  the  Company  nor any Buyer shall issue any
press releases or any other public  statements with respect to the  transactions
contemplated  hereby;  PROVIDED,  HOWEVER,  that the Company  shall be entitled,
without  the prior  approval  of any Buyer,  to make any press  release or other
public   disclosure  with  respect  to  such  transactions  (i)  in  substantial
conformity  with the 8-K Filing and  contemporaneously  therewith and (ii) as is
required by applicable law and  regulations,  including the applicable rules and
regulations of an Eligible Market  (provided that in the case of clause (i) each
Buyer  shall be  consulted  by the  Company  in  connection  with any such press
release or other public disclosure prior to its release).

            (j) ADDITIONAL  REGISTRATION  STATEMENTS.  With the exception of the
registering  of the Company's  2004 Stock Option Plan (pursuant to which options
shall be issued only to employees who work forty (40) hours or more per week and
who enter into lock-up  agreements  pursuant to which they agree not to exercise
such options  until six (6) months after the  Effective  Date (as defined in the
Registration Rights Agreement) of the Registration  Statement (as defined in the
Registration  Rights Agreement)) on Form S-8 pursuant to the 1933 Act until such
time as the Registration Statement is declared effective by the SEC, the Company
will not file a registration statement under the 1933 Act relating to securities
that are not the Securities.

            (k)  VARIABLE  SECURITIES.  With the  exception  of options  granted
pursuant to the  Company's  2004 Stock  Option  Plan,  so long as any  Preferred
Shares or Warrants are outstanding,  the Company shall not, in any manner, issue
or sell any rights,  warrants  or options to  subscribe  for or purchase  Common
Stock or directly or indirectly  convertible into or exchangeable or exercisable
for Common  Stock at a price which  varies or may vary with the market  price of
the Common  Stock,  including by way of one or more  reset(s) to any fixed price
unless the conversion, exchange or exercise price of any such security cannot be
less than the then applicable  Conversion  Price (as defined in the Certificate)
and the then applicable Exercise Price (as defined in the Warrants).

<PAGE>

            (l) CORPORATE EXISTENCE.  So long as any Buyer beneficially owns any
Securities,  the Company shall not be party to any  Fundamental  Transaction (as
defined  in the  Certificate)  unless  the  Company  is in  compliance  with the
applicable  provisions  governing  Fundamental  Transactions  set  forth  in the
Certificate and the Warrants.

            (m)  RESERVATION  OF  SHARES.  The  Company  shall  take all  action
necessary  to at all times have  authorized,  and  reserved  for the  purpose of
issuance,  no less  than the sum of (1) 130% of the  number  of shares of Common
Stock  issuable upon  conversion  of the  outstanding  Preferred  Shares and the
Additional  Investment Right Shares,  (2) 130% of the number of shares of Common
Stock issuable upon exercise of the  outstanding  Warrants,  and (3) 100% of the
number of Preferred  Shares issuable upon exercise of the Additional  Investment
Rights.

            (n)  CONDUCT  OF  BUSINESS.  The  business  of the  Company  and its
Subsidiaries  shall not be  conducted  in  violation  of any law,  ordinance  or
regulation of any Governmental Authority, except where such violations could not
result, either individually or in the aggregate, in a Material Adverse Effect.

            (o) ADDITIONAL ISSUANCES OF SECURITIES.

            (i) For purposes of this Section  4(o),  the  following  definitions
shall apply.

                  (A) "COMMON STOCK EQUIVALENTS"  means,  collectively,  Options
and Convertible Securities.

                  (B)  "CONVERTIBLE  SECURITIES"  means any stock or  securities
(other than Options)  convertible into or exercisable or exchangeable for Common
Stock.

                  (C)  "OPTIONS"  means  any  rights,  warrants  or  options  to
subscribe for or purchase Common Stock or Convertible Securities.

            (ii) From the date hereof until ninety (90)  Business Days after the
Effective Date (as defined in the Registration  Rights  Agreement),  the Company
will not, directly or indirectly,  offer, sell, grant any option to purchase, or
otherwise  dispose  of (or  announce  any  offer,  sale,  grant or any option to
purchase  or other  disposition  of) any of its or the  Subsidiaries'  equity or
equity equivalent  securities,  including without limitation any debt, preferred
stock or other  instrument  or security that is, at any time during its life and
under any  circumstances,  convertible  into or  exchangeable or exercisable for
Common  Stock  or  Common  Stock  Equivalents  (any  such  offer,  sale,  grant,
disposition or announcement being referred to as a "SUBSEQUENT PLACEMENT").

<PAGE>

            (iii) From the Effective  Date until the second  anniversary  of the
Closing  Date,  the  Company  will  not,  directly  or  indirectly,  effect  any
Subsequent  Placement  unless the Company  shall have first  complied  with this
Section 4(o)(iii).

                  (A) The Company shall  deliver to each Buyer a written  notice
(the  "OFFER") of any  proposed or intended  issuance or sale or exchange of the
securities being offered (the "OFFERED  SECURITIES") in a Subsequent  Placement,
which Offer shall (w) identify and describe the Offered Securities, (x) describe
the price and other terms upon which they are to be issued,  sold or  exchanged,
and the  number  or amount  of the  Offered  Securities  to be  issued,  sold or
exchanged,  (y)  identify  the persons or  entities  (if known) to which or with
which the Offered  Securities are to be offered,  issued,  sold or exchanged and
(z)  offer to  issue  and sell to or  exchange  with  such  Buyers  the  Offered
Securities  allocated  among  such  Buyers  (a) based on such  Buyer's  pro rata
portion of the aggregate  number of Preferred  Shares  purchased  hereunder (the
"BASIC AMOUNT"),  and (b) with respect to each Buyer that elects to purchase its
Basic Amount, any additional  portion of the Offered Securities  attributable to
the Basic Amounts of other Buyers as such Buyer shall  indicate it will purchase
or acquire  should the other Buyers  subscribe for less than their Basic Amounts
(the "UNDERSUBSCRIPTION AMOUNT").

                  (B) To accept an Offer,  in whole or in part,  such Buyer must
deliver  a  written  notice  to the  Company  prior  to the end of the TEN  (10)
Business  Day period after  receipt of the Offer (the "OFFER  PERIOD") , setting
forth the portion of the Buyer's Basic Amount that such Buyer elects to purchase
and,  if such  Buyer  shall  elect to  purchase  all of its  Basic  Amount,  the
Undersubscription  Amount, if any, that such Buyer elects to purchase (in either
case, the "NOTICE OF  ACCEPTANCE").  If the Basic Amounts  subscribed for by all
eligible  Buyers are less than the total of all of the Basic Amounts,  then each
Buyer who has set forth an Undersubscription  Amount in its Notice of Acceptance
shall be entitled to purchase,  in addition to the Basic Amounts subscribed for,
the Undersubscription  Amount it has subscribed for; PROVIDED,  HOWEVER, that if
the  Undersubscription  Amounts subscribed for exceed the difference between the
total  of all the  Basic  Amounts  and the  Basic  Amounts  subscribed  for (the
"AVAILABLE  UNDERSUBSCRIPTION  AMOUNT"),  each Buyer who has  subscribed for any
Undersubscription  Amount shall be entitled to purchase only that portion of the
Available  Undersubscription  Amount as the Basic  Amount of such Buyer bears to
the  total  Basic  Amounts  of all  eligible  Buyers  that have  subscribed  for
Undersubscription  Amounts, subject to rounding by the Board of Directors to the
extent its deems reasonably necessary.

                  (C) The  Company  shall have ten (10)  Business  Days from the
expiration  of the Offer Period above to offer,  issue,  sell or exchange all or
any part of such Offered  Securities as to which a Notice of Acceptance  has not
been given by the eligible  Buyers (the "REFUSED  SECURITIES"),  but only to the
offerees  described in the Offer (if so  described  therein) and only upon terms
and conditions (including,  without limitation,  unit prices and interest rates)
that are not more favorable to the acquiring person or persons or less favorable
to the Company than those set forth in the Offer.

<PAGE>

                  (D) In the event the Company  shall  propose to sell less than
all the Refused  Securities  (any such sale to be in the manner and on the terms
specified  in Section  4(o)(iii)(C)  above),  then each  Buyer may,  at its sole
option and in its sole  discretion,  reduce the number or amount of the  Offered
Securities  specified in its Notice of Acceptance to an amount that shall be not
less than the number or amount of the Offered Securities that such Buyer elected
to purchase pursuant to Section 4(o)(iii)(B) above multiplied by a fraction, (i)
the numerator of which shall be the number or amount of Offered  Securities  the
Company  actually  proposes  to  issue,  sell  or  exchange  (including  Offered
Securities to be issued or sold to Buyers pursuant to Section 4(o)(iii)(C) above
prior to such reduction) and (ii) the denominator of which shall be the original
amount  of the  Offered  Securities.  In the  event  that any Buyer so elects to
reduce  the number or amount of Offered  Securities  specified  in its Notice of
Acceptance,  the Company may not issue,  sell or exchange  more than the reduced
number or amount of the Offered Securities unless and until such securities have
again been offered to the Buyers in accordance with Section 4(o)(iii)(A) above.

                  (E) Upon the closing of the issuance,  sale or exchange of all
or less than all of the Refused  Securities,  the Buyers shall  acquire from the
Company,  and the Company  shall  issue to the  Buyers,  the number or amount of
Offered Securities  specified in the Notices of Acceptance,  as reduced pursuant
to Section 4(o)(iii)(C) above if the Buyers have so elected,  upon the terms and
conditions  specified  in the Offer.  The  purchase by the Buyers of any Offered
Securities is subject in all cases to the preparation, execution and delivery by
the Company  and the Buyers of a purchase  agreement  relating  to such  Offered
Securities reasonably satisfactory in form and substance to the Buyers and their
respective counsel.

                  (F) Any Offered Securities not acquired by the Buyers or other
persons in accordance with Section 4(o)(iii)(C) above may not be issued, sold or
exchanged  until  they are  again  offered  to the  eligible  Buyers  under  the
procedures specified in this Agreement.

            (iv) The  restrictions  contained in  subsections  (ii) and (iii) of
this Section 4(o) shall not apply to (I) any Approved Stock Plan; or (II) a bona
fide firm commitment  underwritten public offering with a nationally  recognized
underwriter  which  generates  gross  proceeds  to  the  Company  in  excess  of
$30,000,000 (other than an "at-the-market offering" as defined in Rule 415(a)(4)
under the Securities Act of 1933, as amended, and "equity lines").

<PAGE>

      5. REGISTER; TRANSFER AGENT INSTRUCTIONS.

            (a) REGISTER.  The Company shall maintain at its principal executive
offices (or such other  office or agency of the Company as it may  designate  by
notice to each holder of Preferred  Shares,  Warrants or  Additional  Investment
Rights),  a register for the  Preferred  Shares,  the  Warrants  and  Additional
Investment Rights, in which the Company shall record the name and address of the
Person  in  whose  name  the  Preferred  Shares,  the  Warrants  and  Additional
Investment  Rights  have been  issued  (including  the name and  address of each
transferee), the face amount of Preferred Shares held by such Person, the number
of Warrant  Shares  issuable  upon  exercise of the  Warrants  and the number of
Additional  Investment  Right Shares  issuable upon  exercise of the  Additional
Investment Rights held by such Person.  The Company shall keep the register open
and available at all times during  business hours for inspection of any Buyer or
its legal representatives.

            (b) TRANSFER AGENT INSTRUCTIONS. The Company shall issue irrevocable
instructions to its transfer agent, and any subsequent  transfer agent, to issue
certificates  or  credit  shares  to the  applicable  balance  accounts  at DTC,
registered  in the name of each  Buyer  or its  respective  nominee(s),  for the
Conversion  Shares and the Warrant Shares in such amounts as specified from time
to time by each Buyer to the Company upon conversion of the Preferred Shares and
the  Additional  Investment  Right  Shares or exercise of the  Warrants  and the
Additional  Investment  Rights in the form of  EXHIBIT F  attached  hereto  (the
"IRREVOCABLE  TRANSFER  AGENT  INSTRUCTIONS").  The  Company  warrants  that  no
instruction other than the Irrevocable  Transfer Agent Instructions  referred to
in this Section 5(b), and stop transfer  instructions to give effect to Sections
2(f) and 2(g) hereof,  will be given by the Company to its transfer  agent,  and
that the  Securities  shall  otherwise be freely  transferable  on the books and
records of the Company as and to the extent  provided in this  Agreement and the
other Transaction  Documents.  If a Buyer effects a sale, assignment or transfer
of the Securities in accordance  with Section 2(f), the Company shall permit the
transfer and shall  promptly  instruct  its transfer  agent to issue one or more
certificates or credit shares to the applicable  balance accounts at DTC in such
name and in such  denominations  as specified by such Buyer to effect such sale,
transfer  or  assignment.  In the event that such sale,  assignment  or transfer
involves  Conversion  Shares,  Warrant Shares,  Additional  Investment Rights or
Additional  Investment Right Shares sold, assigned or transferred pursuant to an
effective  registration  statement or in compliance  with Rule 144, the transfer
agent shall issue such Securities to the Buyer,  assignee or transferee,  as the
case may be, without any restrictive  legend.  The Company  acknowledges  that a
breach by it of its  obligations  hereunder  will  cause  irreparable  harm to a
Buyer. Accordingly, the Company acknowledges that the remedy at law for a breach
of its obligations under this Section 5(b) will be inadequate and agrees, in the
event of a breach or threatened  breach by the Company of the provisions of this
Section 5(b), that a Buyer shall be entitled, in addition to all other available
remedies,  to an order and/or  injunction  restraining  any breach and requiring
immediate issuance and transfer,  without the necessity of showing economic loss
and without any bond or other security being required.

      6.  CONDITIONS TO THE COMPANY'S  OBLIGATION TO SELL. The obligation of the
Company  hereunder  to issue  and  sell the  Preferred  Shares  and the  related
Warrants  and  Additional  Investment  Rights to each  Buyer at the  Closing  is
subject to the  satisfaction,  at or before  the  Closing  Date,  of each of the
following conditions,  provided that these conditions are for the Company's sole
benefit and may be waived by the Company at any time in its sole  discretion  by
providing each Buyer with prior written notice thereof:

            (a) Such Buyer and each other Buyer shall have  executed each of the
Transaction  Documents  to which  it is a party  and  delivered  the same to the
Company

<PAGE>

            (b) Such Buyer and each other  Buyer  shall  have  delivered  to the
Company  the  Purchase  Price  (less,  in the case of  Smithfield,  the  amounts
withheld  pursuant  to Section  4(g)) for the  Preferred  Shares and the related
Warrants and Additional Investment Rights being purchased by such Buyer and each
other  Buyer at the  Closing by wire  transfer of  immediately  available  funds
pursuant to the wire instructions provided by the Company.

            (c) The  representations  and warranties of such Buyer shall be true
and correct as of the date when made and as of the  Closing  Date as though made
at that time  (except  for  representations  and  warranties  that speak as of a
specific date),  and such Buyer shall have performed,  satisfied and complied in
all material respects (except for covenants,  agreements and conditions that are
qualified by materiality, which shall be complied with in all respects) with the
covenants, agreements and conditions required by this Agreement to be performed,
satisfied or complied with by such Buyer at or prior to the Closing Date.

      7.  CONDITIONS TO EACH BUYER'S  OBLIGATION TO PURCHASE.  The obligation of
each Buyer hereunder to purchase the Preferred  Shares and the related  Warrants
and Additional  Investment Rights at the Closing is subject to the satisfaction,
at or before the Closing  Date, of each of the  following  conditions,  provided
that these  conditions  are for each  Buyer's  sole benefit and may be waived by
such Buyer at any time in its sole  discretion  by  providing  the Company  with
prior written notice thereof:

            (a) The Company  shall have executed and delivered to such Buyer (i)
each  of the  Transaction  Documents  and  (ii)  certificates  representing  the
Preferred  Shares (in such  denominations  as such Buyer shall  request) and the
related Warrants and Additional Investment Rights (in such amounts as such Buyer
shall  request)  being  purchased by such Buyer at the Closing  pursuant to this
Agreement.

            (b) Such  Buyer  shall  have  received  the  opinion of The Otto Law
Group,  PLLC,  the  Company's  counsel,   dated  as  of  the  Closing  Date,  in
substantially the form of EXHIBIT G attached hereto.

            (c) The  Company  shall have  delivered  to such Buyer a copy of the
Irrevocable  Transfer  Agent  Instructions,  in the form of  EXHIBIT F  attached
hereto,  which  instructions  shall have been delivered to and  acknowledged  in
writing by the Company's transfer agent.

            (d) The Company  shall have  delivered  to such Buyer a  certificate
evidencing  the   incorporation  and  good  standing  of  the  Company  in  such
corporation's  state of  incorporation  issued by the Secretary of State of such
state of incorporation as of a date within 10 days of the Closing Date.

            (e) The Company  shall have  delivered  to such Buyer a  certificate
evidencing  the  Company's  qualification  as a  foreign  corporation  and  good
standing  issued by the Secretary of State of each State in which the Company is
required to qualify to do business as a foreign corporation.

<PAGE>

            (f) The Company shall have  delivered to such Buyer a certified copy
of the Articles of  Incorporation  as certified by the Secretary of State of the
State of Nevada within 10 days of the Closing Date.

            (g) The Company shall have  delivered to such Buyer a certificate in
the form attached  hereto as EXHIBIT H, executed by an executive  officer of the
Company and dated as of the Closing Date, as to (i) the  resolutions  consistent
with  Section  3(b) as adopted by the  Company's  Board of  Directors  in a form
reasonably  acceptable  to such Buyer,  (ii) the Articles of  Incorporation  and
(iii) the Bylaws, each as in effect at the Closing.

            (h) The  representations and warranties of the Company shall be true
and correct as of the date when made and as of the  Closing  Date as though made
at that time  (except  for  representations  and  warranties  that speak as of a
specific date) and the Company shall have  performed,  satisfied and complied in
all material respects (except for covenants,  agreements and conditions that are
qualified by materiality, which shall be complied with in all respects) with the
covenants, agreements and conditions required by the Transaction Documents to be
performed,  satisfied or complied with by the Company at or prior to the Closing
Date.  Such Buyer  shall  have  received a  certificate,  executed  by the Chief
Executive Officer of the Company, dated as of the Closing Date, to the foregoing
effect and as to such other matters as may be reasonably requested by such Buyer
in the form attached hereto as EXHIBIT I.

            (i) The Company shall have delivered to such Buyer a letter from the
Company's  transfer  agent  certifying  the  number of  shares  of Common  Stock
outstanding as of a date within five days of the Closing Date.

            (j) The Company shall have consummated (x) the Intellectual Property
License Agreement with Technology Alternatives, Inc., an Illinois corporation in
accordance with the terms and conditions of the  Intellectual  Property  License
Agreement in the form of EXHIBIT J attached hereto.

            (k) The Common Stock (I) shall be designated for quotation or listed
on the OTC  Bulletin  Board or an  Eligible  Market and (II) shall not have been
suspended by the SEC, the Nasdaq Stock  Market,  the OTC Bulletin  Board or such
Eligible Market from trading on the OTC Bulletin Board or such Eligible  Market,
as applicable nor shall suspension by the SEC, the Nasdaq Stock Market,  the OTC
Bulletin  Board or such  Eligible  Market  have been  threatened  either  (A) in
writing by the SEC, the Nasdaq  Stock  Market,  the OTC  Bulletin  Board or such
Eligible  Market  or  (B) by  falling  below  the  minimum  listing  maintenance
requirements of the OTC Bulletin Board or such Eligible Market.

            (l) The Company shall have obtained all  Governmental  Approvals and
third  party  consents  and  approvals,  if any,  necessary  for the sale of the
Preferred Shares, the Warrants, and the Additional Investment Rights.

            (m) The Company shall have caused James E. Solomon to have delivered
to such Buyer a lock-up agreement in the form attached hereto as EXHIBIT K.

<PAGE>

            (n) The  Company  shall  have  delivered  to such  Buyer the  Escrow
Agreements,  each dated  August _, 2004,  among the Company,  the Escrow  Agent,
James P. Solomon,  Technology  Alternatives,  Inc. and Sunrise  Securities Corp.
(each an  "ESCROW  AGREEMENT")  in the forms  attached  hereto as  EXHIBIT L and
EXHIBIT  M,  respectively,  and each such  Buyer  shall  have  received  written
confirmation  from the Escrow  Agent that the Escrow  Shares (as  defined in the
relevant  Escrow  Agreement)  and the Dispute  Reserve Shares (as defined in the
relevant Escrow Agreement) have been received and duly endorsed in blank.

            (o) The  Company  shall  have  delivered  to such  Buyer  such other
documents  relating to the  transactions  contemplated by this Agreement as such
Buyer or its counsel may reasonably request.

      8. TERMINATION. In the event that the Closing shall not have occurred with
respect  to a Buyer on or before  ten (10) days from the date  hereof due to the
Company's  or such  Buyer's  failure  to  satisfy  the  conditions  set forth in
Sections  6 and 7 above  (and the  nonbreaching  party's  failure  to waive such
unsatisfied  condition(s)),  the  nonbreaching  party  shall  have the option to
terminate this  Agreement  with respect to such breaching  party at the close of
business  on such  date  without  liability  of any  party to any  other  party;
provided, however, that if this Agreement is terminated pursuant to this Section
8, the Company shall remain obligated to reimburse the non-breaching  Buyers for
the expenses described in Section 4(g) above.

      9. MISCELLANEOUS.

            (a)  GOVERNING  LAW;   JURISDICTION;   JURY  TRIAL.   All  questions
concerning the construction,  validity,  enforcement and  interpretation of this
Agreement  shall be  governed  by the  internal  laws of the  State of New York,
without  giving effect to any choice of law or conflict of law provision or rule
(whether of the State of New York or any other  jurisdictions)  that would cause
the  application  of the laws of any  jurisdictions  other than the State of New
York. Each party hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in The City of New York,  Borough of Manhattan,
for the adjudication of any dispute hereunder or in connection  herewith or with
any transaction  contemplated hereby or discussed herein, and hereby irrevocably
waives,  and agrees not to assert in any suit,  action or proceeding,  any claim
that it is not personally  subject to the  jurisdiction of any such court,  that
such suit, action or proceeding is brought in an inconvenient  forum or that the
venue of such  suit,  action  or  proceeding  is  improper.  Each  party  hereby
irrevocably  waives  personal  service of process and consents to process  being
served in any such suit,  action or proceeding by mailing a copy thereof to such
party at the address for such notices to it under this Agreement and agrees that
such service shall constitute good and sufficient  service of process and notice
thereof.  Nothing contained herein shall be deemed to limit in any way any right
to serve process in any manner  permitted by law. EACH PARTY HEREBY  IRREVOCABLY
WAIVES ANY RIGHT IT MAY HAVE,  AND AGREES NOT TO  REQUEST,  A JURY TRIAL FOR THE
ADJUDICATION  OF ANY DISPUTE  HEREUNDER OR IN CONNECTION  WITH OR ARISING OUT OF
THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

            (b)  COUNTERPARTS.  This  Agreement  may be  executed in two or more
identical  counterparts,  all of  which  shall  be  considered  one and the same
agreement and shall become effective when  counterparts have been signed by each
party and  delivered to the other  party;  provided  that a facsimile  signature
shall be  considered  due  execution  and shall be  binding  upon the  signatory
thereto with the same force and effect as if the signature were an original, not
a facsimile signature.

<PAGE>

            (c) HEADINGS.  The headings of this Agreement are for convenience of
reference  and shall not form part of, or affect  the  interpretation  of,  this
Agreement.

            (d)  SEVERABILITY.  If any  provision  of this  Agreement  shall  be
invalid   or   unenforceable   in   any   jurisdiction,   such   invalidity   or
unenforceability  shall  not  affect  the  validity  or  enforceability  of  the
remainder  of  this   Agreement  in  that   jurisdiction   or  the  validity  or
enforceability of any provision of this Agreement in any other jurisdiction.

            (e) ENTIRE  AGREEMENT;  AMENDMENTS.  This  Agreement  supersedes all
other prior oral or written agreements  between the Buyers,  the Company,  their
affiliates  and  Persons  acting on their  behalf  with  respect to the  matters
discussed  herein  and this  Agreement  and the  instruments  referenced  herein
contain  the entire  understanding  of the parties  with  respect to the matters
covered  herein and therein  and,  except as  specifically  set forth  herein or
therein,  neither the Company nor any Buyer makes any representation,  warranty,
covenant or  undertaking  with  respect to such  matters.  No  provision of this
Agreement may be amended  other than by an  instrument in writing  signed by the
Company and the holders of at least a majority  of the  Preferred  Shares or, if
prior to the Closing Date,  the Company and the Buyers listed on the Schedule of
Buyers as being  obligated  to  purchase  at least a majority  of the  Preferred
Shares. No provision hereof may be waived other than by an instrument in writing
signed by the party against whom enforcement is sought.  No such amendment shall
be  effective  to the extent  that it applies to less than all of the holders of
the Preferred Shares then outstanding. No consideration shall be offered or paid
to any Person to amend or consent to a waiver or  modification  of any provision
of any of the  Transaction  Documents  unless  the  same  consideration  also is
offered to all of the parties to the Transaction Documents, holders of Preferred
Shares,  holders of the Warrants,  holders of Additional  Investment  Rights, or
Additional  Investment  Right  Shares as the case may be. The  Company  has not,
directly or  indirectly,  made any  agreements  with any Buyers  relating to the
terms  or  conditions  of  the  transactions  contemplated  by  the  Transaction
Documents except as set forth in the Transaction Documents.

            (f) NOTICES. Any notices,  consents, waivers or other communications
required or permitted to be given under the terms of this  Agreement  must be in
writing  and will be deemed  to have  been  delivered:  (i) upon  receipt,  when
delivered  personally;  (ii)  upon  receipt,  when sent by  facsimile  (provided
confirmation of transmission  is  mechanically or  electronically  generated and
kept on file by the sending party); or (iii) one Business Day after deposit with
an overnight  courier service,  in each case properly  addressed to the party to
receive the same.  The addresses and facsimile  numbers for such  communications
shall be:

                  If to the Company:

                  Dendo Global Corp.
                  3311 N. Kennicott Ave., Suite A
                  Arlington Heights, IL 60004
                  Telephone:        (847) 870-2601
                  Facsimile:        (847) 398-1692
                  Attention:        James E. Solomon

<PAGE>

                  with a copy (which shall not constitute notice) to:

                  The Otto Law Group
                  900 Fourth Avenue
                  Suite 3140
                  Seattle, Washington  98164
                  Telephone:        (206) 262-9545
                  Facsimile:        (206) 262-9513
                  Attention:        David M. Otto, Esq.

                  If to the Transfer Agent:

                  Interwest Transfer Co., Inc.
                  231 E 2100 S #3
                  Salt Lake City, UT 84115
                  Telephone:        (801) 485-5555
                  Facsimile:        (810) 486-0562

<PAGE>

If to a Buyer, to its address and facsimile  number set forth on the Schedule of
Buyers, with copies to such Buyer's representatives as set forth on the Schedule
of Buyers,

                  with a copy (for informational purposes) to:

                  Schulte Roth & Zabel LLP
                  919 Third Avenue
                  New York, New York  10022
                  Telephone:        (212) 756-2000
                  Facsimile:        (212) 593-5955
                  Attention:        Eleazer Klein, Esq.

or to such other address and/or facsimile number and/or to the attention of such
other Person as the  recipient  party has  specified by written  notice given to
each  other  party  five (5) days  prior to the  effectiveness  of such  change.
Written  confirmation  of receipt  (A) given by the  recipient  of such  notice,
consent,  waiver or other  communication,  (B)  mechanically  or  electronically
generated by the sender's facsimile machine containing the time, date, recipient
facsimile  number  and an image of the first  page of such  transmission  or (C)
provided  by an  overnight  courier  service  shall be  rebuttable  evidence  of
personal  service,  receipt by facsimile  or receipt  from an overnight  courier
service in accordance with clause (i), (ii) or (iii) above, respectively.

            (g) SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon and
inure to the benefit of the parties and their respective successors and assigns,
including any purchasers of the Preferred Shares,  the Warrants,  the Additional
Investment Rights or Additional  Investment Right Shares.  The Company shall not
assign this Agreement or any rights or obligations  hereunder  without the prior
written  consent of the holders of at least a majority of the  Preferred  Shares
then outstanding. A Buyer may assign some or all of its rights hereunder without
the consent of the Company, in which event such assignee shall be deemed to be a
Buyer hereunder with respect to such assigned rights.

            (h) NO THIRD PARTY BENEFICIARIES. This Agreement is intended for the
benefit of the parties  hereto and their  respective  permitted  successors  and
assigns, and is not for the benefit of, nor may any provision hereof be enforced
by, any other Person.

            (i) SURVIVAL.  Unless this Agreement is terminated  under Section 8,
the  representations  and warranties of the Company and the Buyers  contained in
Sections 2 and 3, the  agreements and covenants set forth in Sections 4, 5 and 9
shall  survive the  Closing.  Each Buyer shall be  responsible  only for its own
representations, warranties, agreements and covenants hereunder.

            (j) FURTHER ASSURANCES. Each party shall do and perform, or cause to
be done and performed,  all such further acts and things,  and shall execute and
deliver all such other agreements,  certificates,  instruments and documents, as
the other  party may  reasonably  request  in order to carry out the  intent and
accomplish  the  purposes  of  this  Agreement  and  the   consummation  of  the
transactions contemplated hereby.

<PAGE>

            (k) INDEMNIFICATION.  In consideration of each Buyer's execution and
delivery of the  Transaction  Documents and acquiring the Securities  thereunder
and in addition to all of the Company's other  obligations under the Transaction
Documents,  the Company shall defend, protect,  indemnify and hold harmless each
Buyer and each other  holder of the  Securities  and all of their  stockholders,
partners,  members,  officers,  directors,  employees  and  direct  or  indirect
investors  and any of the  foregoing  Persons'  agents or other  representatives
(including,   without   limitation,   those  retained  in  connection  with  the
transactions contemplated by this Agreement)  (collectively,  the "INDEMNITEES")
from and against any and all actions,  causes of action, suits, claims,  losses,
costs,  penalties,  fees,  liabilities  and damages,  and expenses in connection
therewith  (irrespective of whether any such Indemnitee is a party to the action
for  which  indemnification  hereunder  is  sought),  and  including  reasonable
attorneys' fees and disbursements (the "INDEMNIFIED  LIABILITIES"),  incurred by
any  Indemnitee  as a result  of,  or  arising  out of, or  relating  to (a) any
misrepresentation  or  breach  of any  representation  or  warranty  made by the
Company in the Transaction Documents, (b) any breach of any covenant,  agreement
or obligation of the Company contained in the Transaction Documents,  or (c) any
cause of action,  suit or claim  brought or made  against such  Indemnitee  by a
third party (including for these purposes a derivative  action brought on behalf
of the  Company)  and  arising  out of or  resulting  from  (i)  the  execution,
delivery,  performance  or enforcement of the  Transaction  Documents,  (ii) any
transaction  financed  or to be  financed  in  whole  or in  part,  directly  or
indirectly,  with the  proceeds  of the  issuance of the  Securities,  (iii) any
disclosure  made by such Buyer  pursuant to Section  4(i), or (iv) the status of
such Buyer or holder of the Securities as an investor in the Company (other than
in connection with any action such Buyer may have taken). To the extent that the
foregoing  undertaking by the Company may be unenforceable  for any reason,  the
Company shall make the maximum  contribution to the payment and  satisfaction of
each of the Indemnified  Liabilities  which is permissible under applicable law.
Except as otherwise set forth herein,  the mechanics and procedures with respect
to the rights and obligations under this Section 9(k) shall be the same as those
set forth in Section 6 of the Registration Rights Agreement;  provided, however,
that the Company  shall not be required to indemnify  such Buyer for any amounts
paid in settlement of any such loss, claim, damage,  liability or action if such
settlement  is based  upon a  violation  which  occurs in  reliance  upon and in
conformity  with  written  information  furnished  to the  Company by such Buyer
expressly for use in connection with the Transaction Documents.

            (l) NO STRICT CONSTRUCTION. The language used in this Agreement will
be deemed to be the  language  chosen by the  parties  to express  their  mutual
intent, and no rules of strict construction will be applied against any party.

            (m)  REMEDIES.  Each Buyer and each holder of the  Securities  shall
have all rights and  remedies  set forth in the  Transaction  Documents  and all
rights and  remedies  which such holders have been granted at any time under any
other  agreement or contract and all of the rights which such holders have under
any law.  Any Person  having any rights under any  provision  of this  Agreement
shall be entitled to enforce such rights specifically (without posting a bond or
other security),  to recover damages by reason of any breach of any provision of
this Agreement and to exercise all other rights granted by law. Furthermore, the
Company  recognizes  that in the event  that it fails to  perform,  observe,  or
discharge any or all of its obligations under this Agreement,  any remedy at law
may prove to be inadequate  relief to the Buyers.  The Company  therefore agrees
that the Buyers shall be entitled to seek  temporary  and  permanent  injunctive
relief in any such case  without the  necessity  of proving  actual  damages and
without posting a bond or other security.

<PAGE>

            (n)  PAYMENT  SET ASIDE.  To the  extent  that the  Company  makes a
payment or  payments  to the Buyers  hereunder  or  pursuant to any of the other
Transaction  Documents or the Buyers enforce or exercise their rights  hereunder
or thereunder,  and such payment or payments or the proceeds of such enforcement
or exercise or any part  thereof are  subsequently  invalidated,  declared to be
fraudulent  or  preferential,  set aside,  recovered  from,  disgorged by or are
required to be refunded, repaid or otherwise restored to the Company, a trustee,
receiver or any other Person under any law (including,  without limitation,  any
bankruptcy  law, state or federal law, common law or equitable cause of action),
then to the  extent  of any such  restoration  the  obligation  or part  thereof
originally intended to be satisfied shall be revived and continued in full force
and effect as if such  payment had not been made or such  enforcement  or setoff
had not occurred.

            (o)  INDEPENDENT  NATURE OF  BUYERS'  OBLIGATIONS  AND  RIGHTS.  The
obligations  of each Buyer under any  Transaction  Document  are several and not
joint with the obligations of any other Buyer, and no Buyer shall be responsible
in any way for the  performance of the  obligations of any other Buyer under any
Transaction  Document.  Nothing  contained  herein or in any  other  Transaction
Document,  and no action taken by any Buyer pursuant hereto or thereto, shall be
deemed to  constitute  the  Buyers as a  partnership,  an  association,  a joint
venture or any other kind of entity, or create a presumption that the Buyers are
in any way acting in concert or as a group with respect to such  obligations  or
the transactions  contemplated by the Transaction Documents. Each Buyer confirms
that it has  independently  participated  in the  negotiation of the transaction
contemplated hereby with the advice of its own counsel and advisors.  Each Buyer
shall be entitled to  independently  protect and enforce its rights,  including,
without limitation, the rights arising out of this Agreement or out of any other
Transaction  Documents,  and it shall not be necessary for any other Buyer to be
joined as an additional party in any proceeding for such purpose.

                            [SIGNATURE PAGE FOLLOWS]

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Securities  Purchase  Agreement  to be duly
executed as of the date first written above.

                                      COMPANY:

                                      DENDO GLOBAL CORP.

                                      By:/s/
                                         ---------------------------------------
                                         Name: James E. Solomon
                                         Title: President and CEO

                [Signature Page to Securities Purchase Agreement]

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Securities  Purchase  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      SMITHFIELD FIDUCIARY LLC

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

                [Signature Page to Securities Purchase Agreement]

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Securities  Purchase  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      CHEROKEE HOLDINGS II, LLC

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

                [Signature Page to Securities Purchase Agreement]

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Securities  Purchase  Agreement  to be duly
executed as of the date first written above.

                                       BUYERS:

                                       /s/
                                       -----------------------------------------
                                       DEREK CALDWELL

                [Signature Page to Securities Purchase Agreement]

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Securities  Purchase  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      CRANSHIRE CAPITAL LP

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

                [Signature Page to Securities Purchase Agreement]

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Securities  Purchase  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      CRESTVIEW CAPITAL FUNDS

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

                [Signature Page to Securities Purchase Agreement]

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Securities  Purchase  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      DKR OASIS

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

                [Signature Page to Securities Purchase Agreement]

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Securities  Purchase  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      IROQUOIS CAPITAL

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

                [Signature Page to Securities Purchase Agreement]

<PAGE>

                               SCHEDULE OF BUYERS

<TABLE>
<CAPTION>
           (1)                              (2)                            (3)                   (4)

                                                                                         AGGREGATE NUMBER OF
                                                                   AGGREGATE NUMBER OF     INITIAL WARRANT
          BUYER                 ADDRESS AND FACSIMILE NUMBER         PREFERRED SHARES           SHARES
          -----                 ----------------------------         ----------------           ------
<S>                        <C>                                    <C>                    <C>
     Bristol Capital       6363 Sunset Blvd.                              37,500                75,000
      Advisors, LLC        5th Floor
                           Hollywood, CA 90028
                           Attention: Paul Kessler
                                      Amy Wang
                           Facsimile: (310) 696-0333
                           Telephone: (323) 769-2849
                           Residence:

     Caldwell, Derek       641 Lexington Ave.                             12,500                25,000
                           25th Floor
                           New York, NY 10022
                           Attention: Derek Caldwell
                           Facsimile:
                           Telephone: (212) 421-1616
                           Residence:

  Cranshire Capital LP     666 Dundee Rd.                                 31,250                62,500
                           Suite 1901
                           Northbrook, IL 60062
                           Attention: Mitchell Kopin
                           Facsimile:
                           Telephone: (847) 562-9030
                           Residence:

 Crestview Capital Funds   95 Revere                                     212,500               425,000
                           Suite A
                           Northbrook, IL 60062
                           Attention: Stewart Flink
                                      Adam Blonsky
                           Facsimile:
                           Telephone: (847) 418-8302
                           Residence:
</TABLE>

<TABLE>
<CAPTION>
           (1)                     (5)                  (6)                       (7)
                             AGGREGATE NUMBER
                              OF ADDITIONAL       AGGREGATE NUMBER
                            INVESTMENT RIGHT       OF ADDITIONAL         LEGAL REPRESENTATIVE'S
          BUYER                   SHARES           WARRANT SHARES     ADDRESS AND FACSIMILE NUMBER
          -----                   ------           --------------     ----------------------------
<S>                         <C>                  <C>                  <C>
     Bristol Capital             262,500              525,000
      Advisors, LLC

     Caldwell, Derek              87,500              175,000        Schulte Roth & Zabel LLP
                                                                     919 Third Avenue
                                                                     New York, New York  10022
                                                                     Attention:  Eleazer Klein,
                                                                     Esq.
                                                                     Facsimile:  (212) 593-5955
                                                                     Telephone:  (212) 756-2000

  Cranshire Capital LP           218,750              437,500

 Crestview Capital Funds        1,487,500            2,975,000

</TABLE>

<PAGE>

<TABLE>
<CAPTION>

           (1)                              (2)                            (3)                   (4)

                                                                                         AGGREGATE NUMBER OF
                                                                   AGGREGATE NUMBER OF     INITIAL WARRANT
          BUYER                 ADDRESS AND FACSIMILE NUMBER         PREFERRED SHARES           SHARES
          -----                 ----------------------------         ----------------           ------
<S>                        <C>                                    <C>                    <C>

        DKR Oasis          1281 East Main St.                             31,250                62,500
                           3rd Floor
                           Stamford, CT 06902-3565
                           Attention: Ethan Benovitz
                           Facsimile:
                           Telephone: (203) 324-8367
                           Residence:

    Iroquois Capital       641 Lexington Ave.                             31,250                62,500
                           26th Floor
                           New York, NY 10022
                           Attention: Michael Chill
                           Facsimile:
                           Telephone: (212) 920-8171
                           Residence:

      Lachman, Ron         3140 Whisperwoods Court                        18,750                37,500
                           Northbrook, IL  60062
                           Attention: Ron Lachman
                           Facsimile:
                           Telephone: (847) 274-3878
                           Residence:

Smithfield Fiduciary LLC   c/o Highbridge Capital Management, LLC        125,000               250,000
                           9 West 57th Street, 27th Floor
                           New York, New York  10019
                           Attention: Ari J. Storch
                                      Adam J. Chill
                           Facsimile:   (212) 751-0755
                           Telephone:  (212) 287-4720
                           Residence:   Cayman Islands
</TABLE>

<TABLE>
<CAPTION>

           (1)                     (5)                  (6)                       (7)
                             AGGREGATE NUMBER
                              OF ADDITIONAL       AGGREGATE NUMBER
                            INVESTMENT RIGHT       OF ADDITIONAL         LEGAL REPRESENTATIVE'S
          BUYER                   SHARES           WARRANT SHARES     ADDRESS AND FACSIMILE NUMBER
          -----                   ------           --------------     ----------------------------
<S>                         <C>                  <C>                  <C>

        DKR Oasis                218,750              437,500

    Iroquois Capital             218,750              437,500

      Lachman, Ron               131,260              262,500

Smithfield Fiduciary LLC         875,000             1,750,000       Schulte Roth & Zabel LLP
                                                                     919 Third Avenue
                                                                     New York, New York  10022
                                                                     Attention:  Eleazer Klein,
                                                                     Esq.
                                                                     Facsimile:  (212) 593-5955
                                                                     Telephone:  (212) 756-2000

</TABLE>

<PAGE>

                                    EXHIBITS

Exhibit A         Form of Certificate of Designations
Exhibit B         Form of Warrants
Exhibit C         Form of Additional Investment Right
Exhibit D         Form of Additional Warrant
Exhibit E         Form of Registration Rights Agreement
Exhibit F         Form of Irrevocable Transfer Agent Instructions
Exhibit G         Form of Opinion
Exhibit H         Form of Secretary's Certificate
Exhibit I         Form of Officers Certificate
Exhibit J         Intellectual Property License Agreement
Exhibit K         Form of Lock-Up Agreement
Exhibit L         Escrow Agreement
Exhibit M         Escrow Agreement

                                    SCHEDULES

Schedule 3(a)              Subsidiaries
Schedule 3(l)              Absence of Certain Changes
Schedule 3(n)              Conduct of Business; Regulatory Permits
Schedule 3(p)              Transactions with Affiliates
Schedule 3(q)              Capitalization

<PAGE>

                                  SCHEDULE 3(A)

                                  SUBSIDIARIES

None.

<PAGE>

                                  SCHEDULE 3(L)

                           ABSENCE OF CERTAIN CHANGES

None.

<PAGE>

                                  SCHEDULE 3(N)

                     CONDUCT OF BUSINESS; REGULATORY PERMITS

None.

<PAGE>

                                  SCHEDULE 3(P)

                          TRANSACTIONS WITH AFFILIATES

Persons deemed  Affiliates of the Company will be paid no more than an aggregate
amount of $100,000 by the Company prior to the Closing Date in  connection  with
satisfying certain  liabilities of the Company in order to ensure that, prior to
Closing Date, the Company shall have no liabilities..

<PAGE>

                                  SCHEDULE 3(Q)

                                 CAPITALIZATION

                NAME                                          NUMBER OF SHARES

James E. Solomon, President/CEO                                  1,000,000
Peter Lynch, Proposed COO                                         500,000
Barbara Y. Roberts, VP Business Development                       100,000
Cliff Veale, Eastern Regional VP                                   75,000
Irwin W. Williamson, CFO                                           25,000
Jill Wingett, Manager Customer Service                             25,000
Jeff Prior, Product Manager                                        25,000
Lenoard Kusch, Manager Network Solutions                           50,000
Ted Phillips, Manager R&D                                          50,000
Robert Townsend, Project Manager                                   25,000
Charles W. Rainwater, Regional Manager                             25,000
Bryan Kerns, Regional SE Manager                                   25,000
Board Members (4) @ 50,000 Shares                                  200000

TOTAL                                                            2,125,000

Reserved for grants to new key employees
or subsequent grants to above recipients                         2,875,000

Total option shares                                              5,000,000REGISTRATION RIGHTS AGREEMENT

      REGISTRATION RIGHTS AGREEMENT (this  "AGREEMENT"),  dated as of August 20,
2004, by and among Dendo Global Corp., a Nevada  corporation,  with headquarters
located at 3311 N. Kennicott Ave., Suite A, Arlington  Heights,  IL 60004 (to be
renamed  TechAlt,  Inc.) (the  "COMPANY"),  and the undersigned  buyers (each, a
"BUYER" and collectively, the "BUYERS").

      WHEREAS:

      A. In connection with the Securities  Purchase  Agreement by and among the
parties hereto of even date herewith (the "SECURITIES PURCHASE AGREEMENT"),  the
Company  has  agreed,  upon the  terms  and  subject  to the  conditions  of the
Securities Purchase  Agreement,  to issue and sell to the Buyers an aggregate of
(i) Five  Hundred  Thousand  (500,000)  shares (the  "PREFERRED  SHARES") of the
Company's  Series A Convertible  Preferred Stock, par value $.001 per share (the
"PREFERRED  STOCK"),  which will be  convertible  into  shares of the  Company's
common stock, par value $.001 per share (the "COMMON STOCK") (as converted,  the
"INITIAL  CONVERSION  SHARES")  in  accordance  with the terms of the  Company's
Certificate  of  Designations  (the   "CERTIFICATE")   and  (ii)  warrants  (the
"WARRANTS")  which will be exercisable  to purchase  shares of Common Stock (the
"WARRANT   SHARES")  and  (iii)  certain   additional   investment  rights  (the
"ADDITIONAL  INVESTMENT RIGHTS") to purchase up to an aggregate of Three Million
Five  Hundred  Thousand   (3,500,000)   additional  shares  of  Preferred  Stock
("ADDITIONAL  INVESTMENT RIGHT SHARES") which will be convertible into shares of
Common Stock (as converted, the "ADDITIONAL CONVERSION SHARES," and collectively
with the Initial Conversion Shares (the "CONVERSION SHARES").

      B. To induce the Buyers to execute  and deliver  the  Securities  Purchase
Agreement,  the Company has agreed to provide certain  registration rights under
the  Securities  Act  of  1933,  as  amended,  and  the  rules  and  regulations
thereunder, or any similar successor statute (collectively, the "1933 ACT"), and
applicable state securities laws.

      NOW, THEREFORE,  in consideration of the premises and the mutual covenants
contained  herein and other good and  valuable  consideration,  the  receipt and
sufficiency of which are hereby acknowledged, the Company and each of the Buyers
hereby agree as follows:

      1. DEFINITIONS.

      As used in this  Agreement,  the following  terms shall have the following
meanings:

            a. "BUSINESS  DAY" means any day other than Saturday,  Sunday or any
other day on which  commercial  banks in The City of New York are  authorized or
required by law to remain closed.

<PAGE>

            b. "CLOSING DATE" shall have the meaning set forth in the Securities
Purchase Agreement.

            c. "EFFECTIVE  DATE" means the date the  Registration  Statement has
been declared effective by the SEC.

            d. "EFFECTIVENESS DEADLINE" means the date which is (i) in the event
that the  Registration  Statement is not subject to a full review by the SEC, 90
days after the Closing Date or (ii) in the event that the Registration Statement
is subject to a full review by the SEC, 150 days after the Closing Date.

            e. "FILING DEADLINE" means 30 days after the Closing Date.

            f. "INVESTOR"  means a Buyer,  any transferee or assignee thereof to
whom a Buyer  assigns its rights under this  Agreement  and who agrees to become
bound by the provisions of this  Agreement in accordance  with Section 9 and any
transferee  or assignee  thereof to whom a  transferee  or assignee  assigns its
rights under this  Agreement and who agrees to become bound by the provisions of
this Agreement in accordance with Section 9.

            g. "PERSON"  means an individual,  a limited  liability  company,  a
partnership,  a  joint  venture,  a  corporation,  a  trust,  an  unincorporated
organization and governmental or any department or agency thereof.

            h.  "REGISTER,"   "REGISTERED,"  and   "REGISTRATION"   refer  to  a
registration   effected  by  preparing  and  filing  one  or  more  Registration
Statements  in  compliance  with the 1933 Act and  pursuant  to Rule 415 and the
declaration or ordering of  effectiveness of such  Registration  Statement(s) by
the SEC.

            i.  "REGISTRABLE  SECURITIES" means (i) the Conversion Shares issued
or  issuable  upon  conversion  of  the  Preferred  Shares  and  the  Additional
Investment  Right  Shares,  (ii) any  Dividend  Shares  issued  or  issuable  in
connection with the Preferred Shares and the Additional Investment Right Shares,
(iii) the Warrant  Shares  issued or issuable  upon exercise of the Warrants and
(iv) any  shares  of  capital  stock  issued or  issuable  with  respect  to the
Conversion  Shares,  the  Preferred  Shares,  the Dividend  Shares,  the Warrant
Shares,  the  Warrants,  the  Additional  Investment  Rights and the  Additional
Investment  Right  Shares,  as a result  of any  stock  split,  stock  dividend,
recapitalization,  exchange or similar event or otherwise, without regard to any
limitations on conversions of the Preferred Shares and the Additional Investment
Right Shares or exercises of Warrants.

            j.  "REGISTRATION  STATEMENT"  means  a  registration  statement  or
registration  statements  of the Company  filed under the 1933 Act  covering the
Registrable Securities.

            k.  "REQUIRED  HOLDERS"  means the holders of at least a majority of
the Registrable Securities.

<PAGE>

            l. "REQUIRED  REGISTRATION  AMOUNT" means the sum of (i) 130% of the
number  of  Conversion  Shares  issued  and  issuable  as  of  the  trading  day
immediately  preceding the applicable date of determination and (ii) 130% of the
number of Warrant Shares issued and issuable  pursuant to the Warrants as of the
trading day immediately preceding the applicable date of determination,  in each
case subject to adjustment as provided in Section 2(e).

            m. "RULE  415"  means  Rule 415 under the 1933 Act or any  successor
rule providing for offering securities on a continuous or delayed basis.

            n. "SEC" means the United States Securities and Exchange Commission.

      Capitalized  terms used herein and not otherwise defined herein shall have
the respective meanings set forth in the Securities Purchase Agreement.

      2. REGISTRATION.

            a. MANDATORY  REGISTRATION.  The Company shall prepare, and, as soon
as practicable but in no event later than the Filing Deadline, file with the SEC
the  Registration  Statement  on Form  SB-2  covering  the  resale of all of the
Registrable  Securities.  In the event that Form SB-2 is unavailable  for such a
registration,  the Company  shall use such other form as is available for such a
registration,  subject to the  provisions  of Section  2(d);  provided  that the
Company  represents  and warrants that it is currently  eligible to register the
Registrable  Securities  on Form SB-2 and knows of no reason  why it will not be
eligible to so register the Registrable Securities on Form SB-2 on or before the
Filing Deadline and on or before the  Effectiveness  Deadline.  The Registration
Statement prepared pursuant hereto shall register for resale at least the number
of shares of Common  Stock equal to the Required  Registration  Amount as of the
date  the   Registration   Statement  is  initially  filed  with  the  SEC.  The
Registration  Statement  shall  contain  (except if  otherwise  directed  by the
Required Holders) the "SELLING SHAREHOLDERS" and "PLAN OF DISTRIBUTION" sections
in  substantially  the form attached  hereto as EXHIBIT B. The Company shall use
its best efforts to have the Registration  Statement  declared  effective by the
SEC as soon  as  practicable,  but in no  event  later  than  the  Effectiveness
Deadline.

            b.  ALLOCATION  OF  REGISTRABLE  SECURITIES.  The initial  number of
Registrable  Securities included in any Registration Statement and each increase
in the number of Registrable  Securities included therein shall be allocated pro
rata among the Investors  based on the number of Registrable  Securities held by
each  Investor at the time the  Registration  Statement  covering  such  initial
number of Registrable  Securities or increase  thereof is declared  effective by
the SEC. In the event that an Investor sells or otherwise  transfers any of such
Investor's Registrable Securities, each transferee shall be allocated a pro rata
portion of the then remaining number of Registrable  Securities included in such
Registration Statement for such transferor.  Any shares of Common Stock included
in a  Registration  Statement  and which  remain  allocated  to any Person which
ceases to hold any Registrable Securities covered by such Registration Statement
shall be allocated to the remaining  Investors,  pro rata based on the number of
Registrable  Securities  then held by such  Investors  which are covered by such
Registration  Statement.  In no event shall the Company  include any  securities
other than  Registrable  Securities on any  Registration  Statement  without the
prior written consent of the Required Holders.

<PAGE>

            c. LEGAL COUNSEL.  Subject to Section 5 hereof, the Required Holders
shall have the right to select  one legal  counsel  to review  and  oversee  any
registration pursuant to this Section 2, which shall be Schulte Roth & Zabel LLP
or such other  counsel as is  thereafter  designated  in writing by the Required
Holders  prior to the  initiation  of such  other  legal  counsel's  review  and
oversight of any registration  ("LEGAL COUNSEL").  The Company and Legal Counsel
shall  reasonably   cooperate  with  each  other  in  performing  the  Company's
obligations under this Agreement.

            d.  INELIGIBILITY  FOR FORM S-3.  In the event  that Form S-3 is not
available  for  the  registration  of  the  resale  of  Registrable   Securities
hereunder,  the  Company  shall  (i)  register  the  resale  of the  Registrable
Securities on another  appropriate  form  reasonably  acceptable to the Required
Holders and (ii) undertake to register the Registrable Securities on Form S-3 as
soon as such form is available,  provided  that the Company  shall  maintain the
effectiveness of the Registration  Statement then in effect until such time as a
Registration  Statement on Form S-3 covering the Registrable Securities has been
declared effective by the SEC.

            e. SUFFICIENT NUMBER OF SHARES  REGISTERED.  In the event the number
of shares  available  under a Registration  Statement  filed pursuant to Section
2(a) is insufficient to cover all of the Registrable  Securities  required to be
covered by such Registration Statement or an Investor's allocated portion of the
Registrable  Securities  pursuant to Section  2(b),  the Company shall amend the
Registration  Statement, or file a new Registration Statement (on the short form
available  therefor,  if  applicable),  or both,  so as to  cover  at least  the
Required  Registration  Amount, but as of the trading day immediately  preceding
the date of the filing of such amendment or new Registration  Statement, in each
case, as soon as  practicable,  but in any event not later than thirty (30) days
after the necessity  therefor arises.  The Company shall use its best efforts to
cause such amendment  and/or new  Registration  Statement to become effective as
soon as practicable  following the filing thereof. For purposes of the foregoing
provision,  the number of shares available under a Registration  Statement shall
be deemed  "insufficient  to cover all of the Registrable  Securities" if at any
time the  number of  shares  of Common  Stock  available  for  resale  under the
Registration  Statement is less than the product  determined by multiplying  (i)
the Required  Registration Amount by (ii) 0.95. The calculation set forth in the
foregoing  sentence  shall be made  without  regard  to any  limitations  on the
conversion  of the  Preferred  Shares or the  exercise of the  Warrants and such
calculation  shall  assume that the  Preferred  Shares and the Warrants are then
convertible or exercisable  into shares of Common Stock and assuming the maximum
number of  Conversion  Shares and  Warrant  Shares,  as the case may be, will be
issued at the then prevailing  Conversion  Price (as defined in the Certificate)
and Exercise Price (as defined in the Warrants).

<PAGE>

            f. EFFECT OF FAILURE TO FILE AND OBTAIN AND  MAINTAIN  EFFECTIVENESS
OF REGISTRATION  STATEMENT.  If (i) a Registration Statement covering all of the
Registrable  Securities  required to be covered thereby and required to be filed
by the Company  pursuant to this  Agreement  is (A) not filed with the SEC on or
before the respective  Filing Deadline (a "FILING  FAILURE") or (B) not declared
effective  by the SEC on or before the  respective  Effectiveness  Deadline  (an
"EFFECTIVENESS  FAILURE") or (ii) on any day after the  Effective  Date sales of
all of the Registrable  Securities  required to be included on such Registration
Statement  cannot be made  (other  than  during an  Allowable  Grace  Period (as
defined in Section 3(r))  pursuant to such  Registration  Statement  (including,
without  limitation,  because of a failure to keep such  Registration  Statement
effective,  to disclose  such  information  as is necessary for sales to be made
pursuant to such  Registration  Statement or to register a sufficient  number of
shares of Common Stock) (a "MAINTENANCE  FAILURE"),  then, as partial relief for
the  damages to any holder by reason of any such  delay in or  reduction  of its
ability to sell the underlying shares of Common Stock (which remedy shall not be
exclusive  of any other  remedies  available  at law or in equity),  the Company
shall pay to each holder of Registrable Securities relating to such Registration
Statement  an amount in cash  equal to one and  one-half  percent  (1.5%) of the
aggregate  Purchase  Price (as such term is defined in the  Securities  Purchase
Agreement)  of  such  Investor's   Registrable   Securities   included  in  such
Registration  Statement on each of the following  dates: (i) the day of a Filing
Failure and on every  thirtieth  day (pro rated for periods  totaling  less than
thirty days) thereafter  until such Filing Failure is cured;  (ii) the day of an
Effectiveness Failure and on every thirtieth day (pro rated for periods totaling
less than thirty days)  thereafter  until such  Effectiveness  Failure is cured;
(iii) the initial day of a Maintenance  Failure and on every  thirtieth day (pro
rated for  periods  totaling  less  than  thirty  days)  thereafter  until  such
Maintenance  Failure is cured.  The payments to which a holder shall be entitled
pursuant to this  Section  2(f) are  referred to herein as  "REGISTRATION  DELAY
PAYMENTS."  Registration  Delay Payments shall be paid on the earlier of (I) the
last day of the calendar month during which such Registration Delay Payments are
incurred and (II) the third  Business Day after the event or failure giving rise
to the  Registration  Delay Payments is cured. In the event the Company fails to
make Registration  Delay Payments in a timely manner,  such  Registration  Delay
Payments shall bear interest at the rate of 1.5% per month (prorated for partial
months) until paid in full.

      3. RELATED OBLIGATIONS.

      At such time as the Company is obligated to file a Registration  Statement
with the SEC  pursuant to Section  2(a) or 2(e),  the Company  will use its best
efforts to effect the  registration of the Registrable  Securities in accordance
with the intended  method of  disposition  thereof and,  pursuant  thereto,  the
Company shall have the following obligations:

            a. The  Company  shall  promptly  prepare  and  file  with the SEC a
Registration  Statement with respect to the  Registrable  Securities  (but in no
event later than the  applicable  Filing  Deadline)  and use its best efforts to
cause such  Registration  Statement  relating to the  Registrable  Securities to
become effective as soon as practicable after such filing (but in no event later
than the  Effectiveness  Deadline).  The  Company  shall keep each  Registration
Statement  effective  pursuant to Rule 415 at all times until the earlier of (i)
the date as of which the  Investors may sell all of the  Registrable  Securities
covered by such  Registration  Statement  without  restriction  pursuant to Rule
144(k) (or successor thereto) promulgated under the 1933 Act or (ii) the date on
which the Investors  shall have sold all the Registrable  Securities  covered by
such Registration  Statement (the  "REGISTRATION  PERIOD"),  which  Registration
Statement  (including  any amendments or  supplements  thereto and  prospectuses
contained  therein) shall not contain any untrue statement of a material fact or
omit to state a material  fact  required to be stated  therein,  or necessary to
make the statements  therein,  in the light of the  circumstances  in which they
were made,  not  misleading.  The term "best  efforts"  shall mean,  among other
things,  that the Company shall submit to the SEC,  within two (2) Business Days
after the Company learns that no review of a particular  Registration  Statement
will be made by the staff of the SEC or that the staff has no  further  comments
on the  Registration  Statement,  as the case may be, and the  approval of Legal
Counsel pursuant to Section 3(c), a request for acceleration of effectiveness of
such Registration Statement to a time and date not later than 48 hours after the
submission of such request.

<PAGE>

            b. The Company shall  prepare and file with the SEC such  amendments
(including   post-effective   amendments)  and  supplements  to  a  Registration
Statement  and  the  prospectus  used  in  connection  with  such   Registration
Statement,  which  prospectus  is to be filed  pursuant to Rule 424  promulgated
under the 1933 Act,  as may be  necessary  to keep such  Registration  Statement
effective at all times during the Registration  Period, and, during such period,
comply with the  provisions of the 1933 Act with respect to the  disposition  of
all Registrable Securities of the Company covered by such Registration Statement
until such time as all of such  Registrable  Securities shall have been disposed
of in  accordance  with the  intended  methods of  disposition  by the seller or
sellers  thereof  as set forth in such  Registration  Statement.  In the case of
amendments and supplements to a Registration  Statement which are required to be
filed  pursuant to this Agreement  (including  pursuant to this Section 3(b)) by
reason of the  Company  filing a report on Form 10-K or 10-KSB,  as  applicable,
Form 10-Q or 10-QSB,  as applicable,  or Form 8-K or any analogous  report under
the  Securities  Exchange Act of 1934, as amended (the "1934 ACT"),  the Company
shall  have   incorporated  such  report  by  reference  into  the  Registration
Statement, if applicable,  or shall file such amendments or supplements with the
SEC on the same day on which the 1934 Act  report  is filed  which  created  the
requirement for the Company to amend or supplement the Registration Statement.

            c. The Company  shall (A) permit Legal Counsel to review and comment
upon (i) the Registration Statement at least five (5) Business Days prior to its
filing with the SEC and (ii) all amendments and supplements to all  Registration
Statements  (except for reports  incorporated  by  reference  therein)  within a
reasonable  number of days prior to their filing with the SEC, and (B) shall not
unreasonably  reject any  comment  from Legal  Counsel to any such  Registration
Statement or amendment or  supplement  thereto.  The Company  shall not submit a
request for acceleration of the effectiveness of a Registration Statement or any
amendment or supplement  thereto  without the prior  approval of Legal  Counsel,
which consent shall not be unreasonably  withheld.  The Company shall furnish to
Legal Counsel,  without charge, (i) copies of any correspondence from the SEC or
the  staff of the SEC to the  Company  or its  representatives  relating  to any
Registration Statement,  (ii) promptly after the same is prepared and filed with
the SEC, one copy of any Registration  Statement and any  amendment(s)  thereto,
including financial statements and schedules, all documents incorporated therein
by reference,  if requested by an Investor,  and all exhibits and (iii) upon the
effectiveness of any Registration Statement, one copy of the prospectus included
in such Registration  Statement and all amendments and supplements  thereto. The
Company  shall  reasonably  cooperate  with  Legal  Counsel  in  performing  the
Company's obligations pursuant to this Section 3.

            d. The Company  shall  furnish to each  Investor  whose  Registrable
Securities  are included in any  Registration  Statement,  without  charge,  (i)
promptly after the same is prepared and filed with the SEC, at least one copy of
such Registration  Statement and any amendment(s)  thereto,  including financial
statements and schedules,  all documents  incorporated therein by reference,  if
requested by an Investor,  all exhibits and each  preliminary  prospectus,  (ii)
upon the  effectiveness  of any Registration  Statement,  ten (10) copies of the
prospectus  included  in such  Registration  Statement  and all  amendments  and
supplements  thereto  (or such  other  number  of copies  as such  Investor  may
reasonably  request)  and (iii) such other  documents,  including  copies of any
preliminary or final  prospectus,  as such Investor may reasonably  request from
time  to  time  in  order  to  facilitate  the  disposition  of the  Registrable
Securities owned by such Investor.

<PAGE>

            e. The  Company  shall  use its best  efforts  to (i)  register  and
qualify,  unless an exemption from registration and qualification  applies,  the
resale by  Investors of the  Registrable  Securities  covered by a  Registration
Statement  under such  other  securities  or "blue  sky" laws of all  applicable
jurisdictions   in  the  United   States,   (ii)   prepare  and  file  in  those
jurisdictions,   such  amendments  (including  post-effective   amendments)  and
supplements  to such  registrations  and  qualifications  as may be necessary to
maintain the effectiveness  thereof during the Registration  Period,  (iii) take
such other  actions as may be  necessary  to  maintain  such  registrations  and
qualifications in effect at all times during the Registration  Period,  and (iv)
take all  other  actions  reasonably  necessary  or  advisable  to  qualify  the
Registrable Securities for sale in such jurisdictions;  provided,  however, that
the  Company  shall not be required in  connection  therewith  or as a condition
thereto to (x)  qualify to do business  in any  jurisdiction  where it would not
otherwise be required to qualify but for this Section 3(e),  (y) subject  itself
to general taxation in any such  jurisdiction,  or (z) file a general consent to
service of process in any such  jurisdiction.  The Company shall promptly notify
Legal Counsel and each Investor who holds Registrable  Securities of the receipt
by the  Company  of any  notification  with  respect  to the  suspension  of the
registration  or  qualification  of any of the  Registrable  Securities for sale
under the securities or "blue sky" laws of any jurisdiction in the United States
or its  receipt  of  actual  notice  of the  initiation  or  threatening  of any
proceeding for such purpose.

            f. The Company  shall  notify  Legal  Counsel  and each  Investor in
writing, including via facsimile or e-mail followed by overnight courier, of the
happening of any event, as promptly as practicable  after becoming aware of such
event, as a result of which the prospectus included in a Registration Statement,
as then in effect,  includes an untrue  statement of a material fact or omission
to state a material fact required to be stated  therein or necessary to make the
statements  therein,  in light of the circumstances  under which they were made,
not  misleading  (provided  that in no  event  shall  such  notice  contain  any
material, nonpublic information), and, subject to Section 3(r), promptly prepare
a supplement or amendment to such Registration  Statement to correct such untrue
statement  or  omission,  and  deliver  ten (10)  copies of such  supplement  or
amendment to Legal  Counsel and each Investor (or such other number of copies as
Legal Counsel or such Investor may reasonably  request).  The Company shall also
promptly  notify  Legal  Counsel and each  Investor in  writing,  including  via
facsimile or e-mail followed by overnight courier,  (i) when a prospectus or any
prospectus  supplement or  post-effective  amendment has been filed,  and when a
Registration  Statement or any  post-effective  amendment  has become  effective
(notification of such effectiveness shall be delivered to Legal Counsel and each
Investor by  facsimile  or e-mail on the same day of such  effectiveness  and by
overnight mail), (ii) of any request by the SEC for amendments or supplements to
a Registration Statement or related prospectus or related information, and (iii)
of the Company's reasonable  determination that a post-effective  amendment to a
Registration Statement would be appropriate.

            g. The Company shall use its best efforts to prevent the issuance of
any stop order or other suspension of effectiveness of a Registration Statement,
or the suspension of the qualification of any of the Registrable  Securities for
sale in any  jurisdiction  and,  if such an order or  suspension  is issued,  to
obtain the  withdrawal  of such order or  suspension  at the  earliest  possible
moment and to notify  Legal  Counsel  and each  Investor  who holds  Registrable
Securities  being sold of the issuance of such order and the resolution  thereof
or its receipt of actual notice of the  initiation  or threat of any  proceeding
for such purpose.

<PAGE>

            h. For the purposes of establishing a due diligence defense,  at the
reasonable request of any Investor,  the Company shall furnish to such Investor,
on the date of the  effectiveness of the  Registration  Statement and thereafter
from time to time on such dates as an  Investor  may  reasonably  request  (i) a
letter,  dated  such  date,  from the  Company's  independent  certified  public
accountants  in form  and  substance  as is  customarily  given  by  independent
certified public accountants to underwriters in an underwritten public offering,
addressed  to the  Investors,  and (ii) an  opinion,  dated as of such date,  of
counsel representing the Company for purposes of such Registration Statement, in
form,  scope and substance as is  customarily  given in an  underwritten  public
offering, addressed to the Investors.

            i. The  Company  shall  make  available  for  inspection  by (i) any
Investor,  (ii) Legal Counsel and (iii) one firm of  accountants or other agents
retained  by the  Investors  (collectively,  the  "INSPECTORS"),  all  pertinent
financial and other records, and pertinent corporate documents and properties of
the  Company  (collectively,  the  "RECORDS"),  as  shall be  reasonably  deemed
necessary by each  Inspector in order to enable it to exercise its due diligence
responsibility,  and cause the Company's officers, directors, employees, counsel
and the  Company's  independent  certified  public  accountants  to  supply  all
information  which any Inspector may reasonably  request for the purpose of such
due diligence;  provided,  however,  that each Inspector  shall agree to hold in
strict  confidence and shall not make any disclosure  (except to an Investor) or
use of any Record or other  information  which the  Company  determines  in good
faith to be  confidential,  and of which  determination  the  Inspectors  are so
notified,  unless (a) the  disclosure  of such  Records is necessary to avoid or
correct a misstatement or omission in any Registration Statement or is otherwise
required under the 1933 Act, (b) the release of such Records is ordered pursuant
to a final,  non-appealable subpoena or order from a court or government body of
competent  jurisdiction,  or (c) the  information  in such Records has been made
generally  available to the public other than by disclosure in violation of this
or any other  agreement of which the  Inspector  has  knowledge.  Each  Investor
agrees that it shall, upon learning that disclosure of such Records is sought in
or by a court or  governmental  body of competent  jurisdiction or through other
means, give prompt notice to the Company and allow the Company,  at its expense,
to  undertake  appropriate  action  to  prevent  disclosure  of,  or to obtain a
protective order for, the Records deemed confidential. Nothing herein (or in any
other  confidentiality  agreement between the Company and any Investor) shall be
deemed to limit the  Investors'  ability  to sell  Registrable  Securities  in a
manner which is otherwise consistent with applicable laws and regulations.

            j. The Company shall hold in confidence  and not make any disclosure
of  information  concerning  an  Investor  provided  to the  Company  unless (i)
disclosure  of such  information  is  necessary  to comply with federal or state
securities  laws, (ii) the disclosure of such  information is necessary to avoid
or correct a misstatement or omission in any Registration  Statement,  (iii) the
release of such  information  is ordered  pursuant to a subpoena or other final,
non-appealable   order  from  a  court  or   governmental   body  of   competent
jurisdiction,  or (iv) such information has been made generally available to the
public other than by  disclosure  in  violation  of this  Agreement or any other
agreement.  The Company agrees that it shall,  upon learning that  disclosure of
such  information  concerning  an  Investor  is  sought  in  or  by a  court  or
governmental body of competent  jurisdiction or through other means, give prompt
written  notice to such  Investor  and allow such  Investor,  at the  Investor's
expense, to undertake  appropriate action to prevent disclosure of, or to obtain
a protective order for, such information.

<PAGE>

            k. The Company  shall use its best  efforts  either to (i) cause all
the Registrable  Securities covered by a Registration  Statement to be listed on
each securities  exchange on which securities of the same class or series issued
by the Company  are then  listed,  if any,  if the  listing of such  Registrable
Securities is then permitted  under the rules of such  exchange,  or (ii) secure
designation  and  quotation  of all the  Registrable  Securities  covered by the
Registration  Statement on the Nasdaq National Market,  or (iii) if, despite the
Company's best efforts to satisfy the preceding  clause (i) or (ii), the Company
is  unsuccessful  in satisfying the preceding  clause (i) or (ii), to secure the
inclusion  for  quotation  on The Nasdaq  SmallCap  Market for such  Registrable
Securities  and,  without  limiting the generality of the foregoing,  to use its
best  efforts to arrange  for at least two market  makers to  register  with the
National  Association of Securities Dealers,  Inc. ("NASD") as such with respect
to such Registrable  Securities.  The Company shall pay all fees and expenses in
connection with satisfying its obligation under this Section 3(k).

            l.  The  Company  shall   cooperate  with  the  Investors  who  hold
Registrable  Securities being offered and, to the extent applicable,  facilitate
the timely preparation and delivery of certificates (not bearing any restrictive
legend)  representing  the  Registrable  Securities to be offered  pursuant to a
Registration  Statement and enable such certificates to be in such denominations
or amounts,  as the case may be, as the  Investors  may  reasonably  request and
registered in such names as the Investors may request.

            m. If requested by an Investor,  the Company  shall within five days
of  receipt  of notice  from  such  Investor  (i)  incorporate  in a  prospectus
supplement  or   post-effective   amendment  such  information  as  an  Investor
reasonably requests to be included therein relating to the sale and distribution
of Registrable  Securities,  including,  without  limitation,  information  with
respect to the  number of  Registrable  Securities  being  offered or sold,  the
purchase  price being paid  therefor  and any other terms of the offering of the
Registrable  Securities to be sold in such offering;  and (ii) make all required
filings of such prospectus  supplement or  post-effective  amendment after being
notified of the matters to be  incorporated  in such  prospectus  supplement  or
post-effective amendment.

            n. The Company  shall use its best efforts to cause the  Registrable
Securities  covered  by the  Registration  Statement  to be  registered  with or
approved by such other governmental  agencies or authorities as may be necessary
to consummate the disposition of such Registrable Securities.

            o. The  Company  shall  make  generally  available  to its  security
holders as soon as practical,  but not later than 90 days after the close of the
period  covered  thereby,  an earnings  statement  (in form  complying  with the
provisions  of Rule 158 under  the 1933  Act)  covering  a  twelve-month  period
beginning  not later than the first day of the  Company's  fiscal  quarter  next
following the effective date of the Registration Statement.

<PAGE>

            p. The Company  shall  otherwise use its best efforts to comply with
all  applicable  rules  and  regulations  of the  SEC  in  connection  with  any
registration hereunder.

            q. Within two (2) Business Days after a Registration Statement which
covers Registrable Securities is ordered effective by the SEC, the Company shall
deliver,  and shall  cause legal  counsel  for the  Company to  deliver,  to the
transfer  agent for such  Registrable  Securities  (with copies to the Investors
whose  Registrable  Securities  are  included  in such  Registration  Statement)
confirmation that such Registration Statement has been declared effective by the
SEC in the form attached hereto as EXHIBIT A.

            r.  Notwithstanding  anything to the  contrary  herein,  at any time
after the  Registration  Statement has been  declared  effective by the SEC, the
Company may delay the disclosure of material,  non-public information concerning
the  Company  the  disclosure  of which at the  time is not,  in the good  faith
opinion of the Board of Directors  of the Company and its  counsel,  in the best
interest of the Company and, in the opinion of counsel to the Company, otherwise
required (a "GRACE  PERIOD");  provided,  that the Company  shall  promptly  (i)
notify the  Investors  in  writing  of the  existence  of  material,  non-public
information  giving  rise to a Grace  Period  (provided  that in each notice the
Company will not disclose the content of such material,  non-public  information
to the  Investors)  and the date on which the Grace Period will begin,  and (ii)
notify the Investors in writing of the date on which the Grace Period ends; and,
provided  further,  that no Grace Period shall  exceed 10  consecutive  days and
during any 365 day period such Grace Periods shall not exceed an aggregate of 20
days and the first day of any Grace Period must be at least 2 trading days after
the last day of any prior  Grace  Period  (an  "ALLOWABLE  GRACE  PERIOD").  For
purposes of  determining  the length of a Grace Period  above,  the Grace Period
shall begin on and include the date the holders  receive the notice  referred to
in clause  (i) and shall end on and  include  the later of the date the  holders
receive the notice  referred to in clause (ii) and the date  referred to in such
notice. Upon expiration of the Grace Period, the Company shall again be bound by
the first sentence of Section 3(f) with respect to the  information  giving rise
thereto unless such material  non-public  information  is no longer  applicable.
Notwithstanding  anything to the contrary,  the Company shall cause its transfer
agent to  deliver  unlegended  shares  of  Common  Stock to a  transferee  of an
Investor in accordance  with the terms of the Securities  Purchase  Agreement in
connection  with any sale of  Registrable  Securities  with  respect to which an
Investor  has  entered  into a contract  for sale,  and  delivered a copy of the
prospectus included as part of the applicable Registration  Statement,  prior to
the  Investor's  receipt  of the  notice  of a Grace  Period  and for  which the
Investor has not yet settled.

      4. OBLIGATIONS OF THE INVESTORS.

            a. At least five (5)  Business  Days prior to the first  anticipated
filing date of a Registration Statement,  the Company shall notify each Investor
in writing of the  information  the Company  requires from each such Investor if
such  Investor  elects  to have any of such  Investor's  Registrable  Securities
included in such Registration  Statement.  It shall be a condition  precedent to
the  obligations  of the Company to complete the  registration  pursuant to this
Agreement with respect to the  Registrable  Securities of a particular  Investor
that such  Investor  shall  furnish to the Company  such  information  regarding
itself,  the  Registrable  Securities  held by it and  the  intended  method  of
disposition  of the  Registrable  Securities  held by it, as shall be reasonably
required to effect and maintain the  effectiveness  of the  registration of such
Registrable  Securities and shall execute such documents in connection with such
registration as the Company may reasonably request.

<PAGE>

            b. Each Investor,  by such Investor's  acceptance of the Registrable
Securities,  agrees to cooperate with the Company as reasonably requested by the
Company  in  connection  with the  preparation  and  filing of any  Registration
Statement hereunder, unless such Investor has notified the Company in writing of
such  Investor's  election  to  exclude  all  of  such  Investor's   Registrable
Securities from such Registration Statement.

            c. Each  Investor  agrees that,  upon receipt of any notice from the
Company of the  happening of any event of the kind  described in Section 3(g) or
the  first  sentence  of  3(f),  such  Investor  will  immediately   discontinue
disposition of Registrable Securities pursuant to any Registration  Statement(s)
covering such Registrable Securities until such Investor's receipt of the copies
of the  supplemented or amended  prospectus  contemplated by Section 3(g) or the
first  sentence of 3(f) or receipt of notice that no  supplement or amendment is
required.  Notwithstanding anything to the contrary, the Company shall cause its
transfer agent to deliver  unlegended  shares of Common Stock to a transferee of
an Investor in accordance with the terms of the Securities Purchase Agreement in
connection  with any sale of  Registrable  Securities  with  respect to which an
Investor has entered into a contract for sale prior to the Investor's receipt of
a notice from the Company of the happening of any event of the kind described in
Section  3(g) or the first  sentence of 3(f) and for which the  Investor has not
yet settled.

      5. EXPENSES OF REGISTRATION.

      All   reasonable   expenses,   other  than   underwriting   discounts  and
commissions,   incurred   in   connection   with   registrations,   filings   or
qualifications pursuant to Sections 2 and 3, including,  without limitation, all
registration, listing and qualifications fees, printers and accounting fees, and
fees and  disbursements of counsel for the Company shall be paid by the Company.
The  Company  shall also  reimburse  Smithfield  Fiduciary  LLC for the fees and
disbursements  of Legal  Counsel  incurred  in  connection  with  registrations,
filings or  qualifications  pursuant to Sections 2 and 3 of this Agreement which
amount shall be limited to $10,000.

<PAGE>

      6. INDEMNIFICATION.

      In the event any  Registrable  Securities  are included in a  Registration
Statement under this Agreement:

            a. To the fullest  extent  permitted by law, the Company  will,  and
hereby does, indemnify,  hold harmless and defend each Investor,  the directors,
officers, partners,  employees, agents,  representatives of, and each Person, if
any, who  controls  any Investor  within the meaning of the 1933 Act or the 1934
Act (each,  an  "INDEMNIFIED  Person"),  against  any losses,  claims,  damages,
liabilities,  judgments, fines, penalties, charges, costs, reasonable attorneys'
fees, amounts paid in settlement or expenses,  joint or several,  (collectively,
"CLAIMS") incurred in investigating,  preparing or defending any action,  claim,
suit, inquiry,  proceeding,  investigation or appeal taken from the foregoing by
or before any court or governmental,  administrative or other regulatory agency,
body or the SEC,  whether  pending or threatened,  whether or not an indemnified
party is or may be a party thereto ("INDEMNIFIED DAMAGES"), to which any of them
may become subject  insofar as such Claims (or actions or  proceedings,  whether
commenced or threatened, in respect thereof) arise out of or are based upon: (i)
any  untrue  statement  or alleged  untrue  statement  of a  material  fact in a
Registration Statement or any post-effective  amendment thereto or in any filing
made in connection with the  qualification  of the offering under the securities
or other "blue sky" laws of any jurisdiction in which Registrable Securities are
offered  ("BLUE SKY  FILING"),  or the  omission or alleged  omission to state a
material fact required to be stated  therein or necessary to make the statements
therein not misleading, (ii) any untrue statement or alleged untrue statement of
a material  fact  contained in any  preliminary  prospectus if used prior to the
effective  date  of such  Registration  Statement,  or  contained  in the  final
prospectus  (as  amended or  supplemented,  if the Company  files any  amendment
thereof or supplement  thereto with the SEC) or the omission or alleged omission
to state  therein  any  material  fact  necessary  to make the  statements  made
therein,  in light of the circumstances  under which the statements therein were
made, not misleading, (iii) any violation or alleged violation by the Company of
the 1933 Act, the 1934 Act, any other law, including,  without  limitation,  any
state securities law, or any rule or regulation thereunder relating to the offer
or sale of the Registrable  Securities  pursuant to a Registration  Statement or
(iv) any material  violation  of this  Agreement  (the matters in the  foregoing
clauses (i) through (iv) being, collectively,  "VIOLATIONS"). Subject to Section
6(c),  the Company shall  reimburse the  Indemnified  Persons,  promptly as such
expenses  are  incurred  and are due and  payable,  for any legal  fees or other
reasonable  expenses  incurred  by  them in  connection  with  investigating  or
defending  any such Claim.  Notwithstanding  anything to the contrary  contained
herein, the indemnification  agreement contained in this Section 6(a): (i) shall
not apply to a Claim by an  Indemnified  Person  arising  out of or based upon a
Violation  which  occurs in reliance  upon and in  conformity  with  information
furnished  in  writing  to the  Company  by such  Indemnified  Person  for  such
Indemnified  Person  expressly for use in connection with the preparation of the
Registration  Statement or any such amendment thereof or supplement  thereto, if
such  prospectus  was timely made  available by the Company  pursuant to Section
3(d);  (ii) with respect to any preliminary  prospectus,  shall not inure to the
benefit  of any such  person  from  whom the  person  asserting  any such  Claim
purchased the  Registrable  Securities  that are the subject  thereof (or to the
benefit of any person  controlling  such  person)  if the  untrue  statement  or
omission of material fact contained in the preliminary  prospectus was corrected
in the  prospectus,  as then amended or  supplemented,  if such  prospectus  was
timely  made  available  by the  Company  pursuant  to  Section  3(d),  and  the
Indemnified  Person was  promptly  advised in writing  not to use the  incorrect
prospectus  prior to the use giving  rise to a  Violation  and such  Indemnified
Person,  notwithstanding  such advice,  used it or failed to deliver the correct
prospectus  as required by the 1933 Act and such correct  prospectus  was timely
made  available  pursuant to Section  3(d);  (iii) shall not be available to the
extent  such Claim is based on a failure of the  Investor to deliver or to cause
to be delivered  the  prospectus  made  available  by the  Company,  including a
corrected prospectus, if such prospectus or corrected prospectus was timely made
available by the Company  pursuant to Section 3(d);  and (iv) shall not apply to
amounts paid in settlement of any Claim if such  settlement is effected  without
the  prior  written  consent  of  the  Company,   which  consent  shall  not  be
unreasonably  withheld or delayed. Such indemnity shall remain in full force and
effect regardless of any  investigation  made by or on behalf of the Indemnified
Person and shall  survive the  transfer  of the  Registrable  Securities  by the
Investors pursuant to Section 9.

<PAGE>

            b. In  connection  with  any  Registration  Statement  in  which  an
Investor  is  participating,  each such  Investor  agrees to  severally  and not
jointly indemnify,  hold harmless and defend, to the same extent and in the same
manner as is set forth in Section 6(a), the Company, each of its directors, each
of its officers who signs the  Registration  Statement and each Person,  if any,
who  controls  the  Company  within the  meaning of the 1933 Act or the 1934 Act
(each,  an  "INDEMNIFIED  PARTY"),  against any Claim or Indemnified  Damages to
which  any of them may  become  subject,  under  the 1933  Act,  the 1934 Act or
otherwise,  insofar as such  Claim or  Indemnified  Damages  arise out of or are
based upon any  Violation,  in each case to the extent,  and only to the extent,
that such  Violation  occurs in reliance  upon and in  conformity  with  written
information  furnished  to the  Company by such  Investor  expressly  for use in
connection with such Registration Statement;  and, subject to Section 6(c), such
Investor will  reimburse any legal or other expenses  reasonably  incurred by an
Indemnified Party in connection with  investigating or defending any such Claim;
provided,  however,  that the indemnity agreement contained in this Section 6(b)
and the agreement with respect to contribution  contained in Section 7 shall not
apply to amounts paid in settlement of any Claim if such  settlement is effected
without the prior written  consent of such Investor,  which consent shall not be
unreasonably withheld or delayed; provided,  further, however, that the Investor
shall be liable  under  this  Section  6(b) for only  that  amount of a Claim or
Indemnified  Damages as does not exceed the net  proceeds to such  Investor as a
result  of the sale of  Registrable  Securities  pursuant  to such  Registration
Statement.  Such indemnity  shall remain in full force and effect  regardless of
any  investigation  made by or on  behalf  of such  Indemnified  Party and shall
survive the transfer of the Registrable  Securities by the Investors pursuant to
Section 9.  Notwithstanding  anything  to the  contrary  contained  herein,  the
indemnification  agreement  contained  in this  Section 6(b) with respect to any
preliminary  prospectus shall not inure to the benefit of any Indemnified  Party
if  the  untrue  statement  or  omission  of  material  fact  contained  in  the
preliminary  prospectus  was corrected on a timely basis in the  prospectus,  as
then amended or supplemented.

<PAGE>

            c. Promptly  after receipt by an  Indemnified  Person or Indemnified
Party  under  this  Section  6 of notice of the  commencement  of any  action or
proceeding  (including any governmental action or proceeding) involving a Claim,
such  Indemnified  Person or  Indemnified  Party  shall,  if a Claim in  respect
thereof is to be made  against  any  indemnifying  party  under this  Section 6,
deliver to the indemnifying party a written notice of the commencement  thereof,
and the  indemnifying  party shall have the right to participate in, and, to the
extent the indemnifying  party so desires,  jointly with any other  indemnifying
party similarly  noticed,  to assume control of the defense thereof with counsel
mutually  satisfactory to the indemnifying  party and the Indemnified  Person or
the  Indemnified  Party,  as  the  case  may  be;  provided,  however,  that  an
Indemnified  Person or Indemnified  Party shall have the right to retain its own
counsel  with the fees  and  expenses  of not  more  than one  counsel  for such
Indemnified  Person or Indemnified  Party to be paid by the indemnifying  party,
if, in the reasonable opinion of counsel retained by the indemnifying party, the
representation  by such counsel of the Indemnified  Person or Indemnified  Party
and the  indemnifying  party would be  inappropriate  due to actual or potential
differing interests between such Indemnified Person or Indemnified Party and any
other party  represented by such counsel in such  proceeding.  In the case of an
Indemnified  Person,  legal  counsel  referred to in the  immediately  preceding
sentence  shall be selected by the Required  Holders to which the Claim relates.
The  Indemnified  Party or  Indemnified  Person shall  cooperate  fully with the
indemnifying  party in connection  with any  negotiation  or defense of any such
action or Claim by the indemnifying  party and shall furnish to the indemnifying
party  all  information   reasonably  available  to  the  Indemnified  Party  or
Indemnified Person which relates to such action or Claim. The indemnifying party
shall keep the  Indemnified  Party or  Indemnified  Person fully apprised at all
times as to the  status  of the  defense  or any  settlement  negotiations  with
respect thereto. No indemnifying party shall be liable for any settlement of any
action,  claim  or  proceeding  effected  without  its  prior  written  consent,
provided,  however, that the indemnifying party shall not unreasonably withhold,
delay or condition its consent.  No indemnifying party shall,  without the prior
written consent of the Indemnified Party or Indemnified Person, consent to entry
of any judgment or enter into any settlement or other  compromise which does not
include as an unconditional term thereof the giving by the claimant or plaintiff
to such Indemnified Party or Indemnified  Person of a release from all liability
in respect to such Claim or litigation.  Following  indemnification  as provided
for hereunder,  the indemnifying  party shall be subrogated to all rights of the
Indemnified Party or Indemnified Person with respect to all third parties, firms
or corporations  relating to the matter for which indemnification has been made.
The  failure  to  deliver  written  notice to the  indemnifying  party  within a
reasonable  time of the  commencement  of any such action shall not relieve such
indemnifying  party of any liability to the  Indemnified  Person or  Indemnified
Party under this Section 6, except to the extent that the indemnifying  party is
prejudiced in its ability to defend such action.

<PAGE>

            d. The  indemnification  required by this Section 6 shall be made by
periodic  payments of the amount thereof during the course of the  investigation
or defense, as and when bills are received or Indemnified Damages are incurred.

            e. The indemnity agreements contained herein shall be in addition to
(i) any cause of action or similar right of the Indemnified Party or Indemnified
Person against the  indemnifying  party or others,  and (ii) any liabilities the
indemnifying party may be subject to pursuant to the law.

      7. CONTRIBUTION.

      To the extent any  indemnification  by an indemnifying party is prohibited
or  limited  by  law,  the  indemnifying   party  agrees  to  make  the  maximum
contribution  with respect to any amounts for which it would otherwise be liable
under Section 6 to the fullest extent permitted by law; provided, however, that:
(i) no person  involved in the sale of  Registrable  Securities  which person is
guilty of fraudulent  misrepresentation  (within the meaning of Section 11(f) of
the 1933 Act) in  connection  with such sale shall be entitled  to  contribution
from any person  involved  in such sale of  Registrable  Securities  who was not
guilty of fraudulent  misrepresentation;  and (ii) contribution by any seller of
Registrable  Securities shall be limited in amount to the net amount of proceeds
received by such seller from the sale of such Registrable Securities pursuant to
such Registration Statement.

      8. REPORTS UNDER THE 1934 ACT.

      Until  the  date on  which  (A) the  Investors  shall  have  sold  all the
Conversion Shares and the Warrant Shares and (B) none of the Preferred Shares or
Warrants is  outstanding,  with a view to making  available to the Investors the
benefits of Rule 144 promulgated under the 1933 Act or any other similar rule or
regulation  of the  SEC  that  may at any  time  permit  the  Investors  to sell
securities of the Company to the public without  registration  ("RULE 144"), the
Company agrees to:

<PAGE>

            a. make and keep public  information  available,  as those terms are
understood and defined in Rule 144;

            b.  file  with the SEC in a timely  manner  all  reports  and  other
documents required of the Company under the 1933 Act and the 1934 Act so long as
the Company  remains  subject to such  requirements  (it being  understood  that
nothing herein shall limit the Company's  obligations  under Section 4(c) of the
Securities  Purchase  Agreement)  and the  filing  of  such  reports  and  other
documents is required for the applicable provisions of Rule 144; and

            c.  furnish  to  each   Investor  so  long  as  such  Investor  owns
Registrable  Securities,  promptly upon request,  (i) a written statement by the
Company,  if true, that it has complied with the reporting  requirements of Rule
144,  the 1933 Act and the 1934 Act,  (ii) a copy of the most  recent  annual or
quarterly report of the Company and such other reports and documents so filed by
the Company,  and (iii) such other information as may be reasonably requested to
permit  the  Investors  to sell such  securities  pursuant  to Rule 144  without
registration.

      9. ASSIGNMENT OF REGISTRATION RIGHTS.

      The rights under this Agreement shall be  automatically  assignable by the
Investors  to any  transferee  of  Registrable  Securities  if: (i) the Investor
agrees in writing with the  transferee or assignee to assign such rights,  and a
copy of such  agreement  is furnished  to the Company  within a reasonable  time
after such assignment;  (ii) the Company is, within a reasonable time after such
transfer  or  assignment,  furnished  with  written  notice  of (a) the name and
address of such  transferee or assignee,  and (b) the securities with respect to
which  such  registration  rights  are  being  transferred  or  assigned;  (iii)
immediately  following  such transfer or assignment  the further  disposition of
such  securities by the transferee or assignee is restricted  under the 1933 Act
and applicable state securities laws; and (iv) at or before the time the Company
receives the written  notice  contemplated  by clause (ii) of this  sentence the
transferee or assignee  agrees in writing with the Company to be bound by all of
the provisions  contained  herein.  In the event the rights under this Agreement
are assigned,  the Investor  shall notify the Company within twenty (20) days of
said assignment.

      10. AMENDMENT OF REGISTRATION RIGHTS.

      Provisions of this Agreement may be amended and the observance thereof may
be waived (either generally or in a particular instance and either retroactively
or prospectively), only with the written consent of the Company and the Required
Holders.  Any amendment or waiver  effected in  accordance  with this Section 10
shall be binding upon each Investor and the Company.  No such amendment shall be
effective  to the extent  that it applies to less than all of the holders of the
Registrable Securities.  No consideration shall be offered or paid to any Person
to amend or consent to a waiver or  modification of any provision of any of this
Agreement unless the same consideration also is offered to all of the parties to
this Agreement.

<PAGE>

      11. MISCELLANEOUS.

            a. A Person  is  deemed  to be a holder  of  Registrable  Securities
whenever  such  Person  owns or is  deemed  to own of  record  such  Registrable
Securities.  If  the  Company  receives  conflicting  instructions,  notices  or
elections  from  two or  more  Persons  with  respect  to the  same  Registrable
Securities,  the  Company  shall act upon the basis of  instructions,  notice or
election received from the such record owner of such Registrable Securities.

            b. Any notices,  consents,  waivers or other communications required
or  permitted to be given under the terms of this  Agreement  must be in writing
and will be deemed to have been  delivered:  (i) upon  receipt,  when  delivered
personally;  (ii) upon receipt, when sent by facsimile (provided confirmation of
transmission is mechanically or electronically generated and kept on file by the
sending  party);  or (iii) one  Business  Day after  deposit  with a  nationally
recognized  overnight  delivery service,  in each case properly addressed to the
party to  receive  the  same.  The  addresses  and  facsimile  numbers  for such
communications shall be:

                  If to the Company:

                                    Dendo Global Corp.
                                    3311 N. Kennicott Ave., Suite A
                                    Arlington Heights, IL 60004
                                    Telephone:       (847) 870-2601
                                    Facsimile:       (847) 398-1692
                                    Attention:       Mr. James E. Solomon
                                                     President and C.E.O.

                  With a copy (which shall not constitute notice) to:

                                    The Otto Law Group
                                    900 Fourth Avenue
                                    Suite 3140
                                    Seattle, Washington 98164
                                    Telephone:       (206) 262-9545
                                    Facsimile:       (206) 262-9513
                                    Attention:       David M. Otto, Esq.

                  If to Legal Counsel:

                                    Schulte Roth & Zabel LLP
                                    919 Third Avenue
                                    New York, New York 10022
                                    Telephone:       (212) 756-2000
                                    Facsimile:       (212) 593-5955
                                    Attention:       Eleazer Klein, Esq.

<PAGE>

If to a Buyer, to its address and facsimile  number set forth on the Schedule of
Buyers attached hereto, with copies to such Buyer's representatives as set forth
on the Schedule of Buyers,  or to such other  address  and/or  facsimile  number
and/or  to the  attention  of such  other  person  as the  recipient  party  has
specified by written notice given to each other party five (5) days prior to the
effectiveness of such change.  Written  confirmation of receipt (A) given by the
recipient  of  such  notice,  consent,   waiver  or  other  communication,   (B)
mechanically  or  electronically  generated  by the sender's  facsimile  machine
containing the time, date,  recipient facsimile number and an image of the first
page of such  transmission  or (C)  provided by a courier or  overnight  courier
service shall be rebuttable  evidence of personal service,  receipt by facsimile
or receipt from a nationally recognized overnight delivery service in accordance
with clause (i), (ii) or (iii) above, respectively.

            c.  Failure of any party to exercise  any right or remedy under this
Agreement or otherwise,  or delay by a party in exercising such right or remedy,
shall not operate as a waiver thereof.

            d. All questions concerning the construction,  validity, enforcement
and  interpretation  of this Agreement shall be governed by the internal laws of
the State of New York, without giving effect to any choice of law or conflict of
law  provision  or  rule  (whether  of the  State  of  New  York  or  any  other
jurisdictions) that would cause the application of the laws of any jurisdictions
other than the State of New York. Each party hereby  irrevocably  submits to the
exclusive  jurisdiction  of the state and federal courts sitting the City of New
York, borough of Manhattan,  for the adjudication of any dispute hereunder or in
connection  herewith or with any  transaction  contemplated  hereby or discussed
herein,  and hereby  irrevocably  waives,  and agrees not to assert in any suit,
action  or  proceeding,  any  claim  that it is not  personally  subject  to the
jurisdiction of any such court,  that such suit, action or proceeding is brought
in an inconvenient forum or that the venue of such suit, action or proceeding is
improper.  Each party hereby  irrevocably waives personal service of process and
consents  to process  being  served in any such suit,  action or  proceeding  by
mailing a copy thereof to such party at the address for such notices to it under
this Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof.  Nothing contained herein shall be deemed
to limit in any way any right to serve  process in any manner  permitted by law.
If any  provision of this  Agreement  shall be invalid or  unenforceable  in any
jurisdiction,  such invalidity or unenforceability shall not affect the validity
or enforceability of the remainder of this Agreement in that jurisdiction or the
validity or  enforceability  of any  provision  of this  Agreement  in any other
jurisdiction.  EACH PARTY HEREBY  IRREVOCABLY  WAIVES ANY RIGHT IT MAY HAVE, AND
AGREES  NOT TO  REQUEST,  A JURY  TRIAL  FOR  THE  ADJUDICATION  OF ANY  DISPUTE
HEREUNDER  OR IN  CONNECTION  HEREWITH OR ARISING OUT OF THIS  AGREEMENT  OR ANY
TRANSACTION CONTEMPLATED HEREBY.

            e. This Agreement and the other Transaction Documents (as defined in
the Securities  Purchase  Agreement)  constitute the entire  agreement among the
parties hereto with respect to the subject matter hereof and thereof.  There are
no  restrictions,  promises,  warranties or  undertakings,  other than those set
forth  or  referred  to  herein  and  therein.  This  Agreement  and  the  other
Transaction  Documents  supersede all prior agreements and understandings  among
the parties hereto with respect to the subject matter hereof and thereof.

            f. Subject to the  requirements  of Section 9, this Agreement  shall
inure to the benefit of and be binding upon the permitted successors and assigns
of each of the parties hereto.

<PAGE>

            g. The headings in this  Agreement are for  convenience of reference
only and shall not limit or otherwise affect the meaning hereof.

            h. This Agreement may be executed in identical counterparts, each of
which shall be deemed an original but all of which shall  constitute one and the
same agreement.  This Agreement,  once executed by a party,  may be delivered to
the other party hereto by  facsimile  transmission  of a copy of this  Agreement
bearing the signature of the party so delivering this Agreement.

            i.  Each  party  shall  do and  perform,  or  cause  to be done  and
performed,  all such further acts and things,  and shall execute and deliver all
such other  agreements,  certificates,  instruments and documents,  as the other
party may reasonably request in order to carry out the intent and accomplish the
purposes of this Agreement and the consummation of the transactions contemplated
hereby.

            j. All consents and other determinations  required to be made by the
Investors  pursuant to this Agreement shall be made, unless otherwise  specified
in  this  Agreement,  by  the  Required  Holders,  determined  as if  all of the
Preferred  Shares held by Investors  then  outstanding  have been converted into
Registrable Securities and all Warrants then outstanding have been exercised for
Registrable  Securities  without regard to any  limitations on conversion of the
Preferred Shares or on exercises of the Warrants.

            k. The  language  used in this  Agreement  will be  deemed to be the
language  chosen by the parties to express  their mutual  intent and no rules of
strict construction will be applied against any party.

            l. This  Agreement is intended for the benefit of the parties hereto
and  their  respective  permitted  successors  and  assigns,  and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person.

                                   * * * * * *

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Registration  Rights  Agreement  to be duly
executed as of the date first written above.

                                    COMPANY:

                                    DENDO GLOBAL CORP.

                                    By:/s/
                                       -----------------------------------------
                                    Name: James E. Solomon
                                    Title: President and Chief Executive Officer

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Registration  Rights  Agreement  to be duly
executed as of the date first written above.

                                     BUYERS:

                                     SMITHFIELD FIDUCIARY LLC

                                     By:/s/
                                        ----------------------------------------
                                        Name:
                                        Title:

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Registration  Rights  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      CHEROKEE HOLDINGS II, LLC

                                     By:/s/
                                        ----------------------------------------
                                        Name:
                                        Title:

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Registration  Rights  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      /s/
                                      ------------------------------------
                                      DEREK CALDWELL

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Registration  Rights  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      CRANSHIRE CAPITAL LP

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Registration  Rights  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      CRESTVIEW CAPITAL FUNDS

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Registration  Rights  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      DKR OASIS

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

<PAGE>

      IN  WITNESS  WHEREOF,  each  Buyer  and  the  Company  have  caused  their
respective  signature  page to this  Registration  Rights  Agreement  to be duly
executed as of the date first written above.

                                      BUYERS:

                                      IROQUOIS CAPITAL

                                      By:/s/
                                         ---------------------------------------
                                         Name:
                                         Title:

<PAGE>

<TABLE>
<CAPTION>

<S>               <C>                <C>              <C>             <C>              <C>           <C>
----------------------------------------------------------------------------------------------------------------------
Buyer             Address            Agreggate        Agregate         Aggregate         Aggregate    Legal
                                     Number of        Number of        Number of         Number of    Representative's
                                     Preferred        Initial          Additional        Additional   Adress and
                                     Shares           Warrant Shares   Investment        Warrant      Facsimile
                                                                       Right Shares      Shares       Number
----------------------------------------------------------------------------------------------------------------------
Caldwell, Derek   641 Lexington      12,500           25,000           87,500            175,000      Schulte Roth &
                  Ave.                                                                                Zabel LLP
                  25th Floor                                                                          919 Third
                  New York, NY                                                                        Avenue
                  10022                                                                               New York, New
                  Attention:                                                                          York 10022
                  Derek Caldwell                                                                      Attention:
                  Facsimile:                                                                          Eleazer Klein,
                  Telephone: (212)                                                                    Esq.
                  421-1616                                                                            Facsimile:
                  Residence:                                                                          (212) 593-5955
                                                                                                      Telephone:
                                                                                                      (212) 756-200
----------------------------------------------------------------------------------------------------------------------
Cherokee          PO Box 220126      56,250           112,500          393,760           787,500
Holdings II LLC   Great Neck NY
                  11022-0126
                  Attention:  Sam
                  Masri
                  Facsimile:
                  (516) 466-6257
                  Telephone:
                  (917) 622-8628
                  Residence:
----------------------------------------------------------------------------------------------------------------------
Cranshire         666 Dundee Rd.     31,250           62,500           218,750           437,500
Capital LP        Suite 1901
                  Northbrook, IL
                  60062
                  Attention:
                  Mtichell Kopin
                  Facsimile:
                  Telephone:
                  (847) 562-9030
                  Residence:
----------------------------------------------------------------------------------------------------------------------
Crestview         95 Revere          212,500          425,000          1,487,500         2,975,000
Capital Master,   Suite A
LLC               Northbrook, IL
                  60062
                  Attention:
                  Stewart Flink
                  Adam Blonksky
                  Facsimile:
                  Telephone: (847)
                  418-8302
                  Residence:
----------------------------------------------------------------------------------------------------------------------
DKR SoundShore    1281 East Main     31,250           62,500           218,750           437,500
Oasis Holding     St.
Fund Ltd.         3rd Floor
                  Stamford, CT
                  06902-3565
                  Attention: Ethan
                  Benovitz
                  Facsimile:
                  Telephone: (203)
                  324-8367
                  Residence:
----------------------------------------------------------------------------------------------------------------------
Iroquois          641 Lexington      31,250           62,500           218,750           437,500
Capital LP        Ave.
                  26th Floor
                  New York, NY
                  10022
                  Attention:
                  Michael Chill
                  Facsimile:
                  Telephone: (212)
                  920-8171
                  Residence:
----------------------------------------------------------------------------------------------------------------------
Smithfield        C/o Highbridge     125,000          250,000          875,000           1,750,000    Schulte Roth &
Fiduciary LLC     Capital                                                                             Zabel LLP
                  Management, LLC                                                                     919 Third
                  9 West 57th                                                                         Avenue
                  Street, 27th                                                                        New York, New
                  Floor                                                                               York 10022
                  New York, New                                                                       Attention:
                  York 10019                                                                          Eleazer Klein,
                  Attention: Ari                                                                      Esq.
                  J. Storch                                                                           Facsimile:
                  Adam J. Chill                                                                       (212) 593-5955
                  Facsimile: (212)                                                                    Telephone:
                  751-0755                                                                            (212) 756-200
                  Telephone: (212)
                  287-4720
                  Residence:
                  Cayman Islands
----------------------------------------------------------------------------------------------------------------------
</TABLE>

<PAGE>

                                                                       EXHIBIT A

                         FORM OF NOTICE OF EFFECTIVENESS
                            OF REGISTRATION STATEMENT

Interwest Transfer Co, Inc
231 E 2100 S #3
Salt Lake City, UT 84115
Attention: ____________

      Re:   DENDO GLOBAL CORP.

Ladies and Gentlemen:

      We are counsel to Dendo Global Corp., a Nevada  corporation (to be renamed
TechAlt,  Inc.) (the "COMPANY"),  and have represented the Company in connection
with that certain  Securities  Purchase  Agreement  (the  "PURCHASE  AGREEMENT")
entered   into  by  and  among  the  Company  and  the  buyers   named   therein
(collectively,  the  "HOLDERS")  pursuant  to which  the  Company  issued to the
Holders shares of its Series A Convertible  Preferred Stock, par value $.001 per
share, (the "PREFERRED SHARES")  convertible into shares of the Company's common
stock,  par value  $.001 per share  (the  "COMMON  STOCK")  (as  converted,  the
"INITIAL CONVERSION SHARES"),  warrants (the "WARRANTS")  exercisable for shares
of  Common  Stock  (the  "WARRANT  SHARES")  and  additional  investment  rights
exercisable  for Preferred  Shares (the  "ADDITIONAL  INVESTMENT  RIGHT SHARES")
convertible  into  Common  Stock,  (as  converted,  the  "ADDITIONAL  CONVERSION
SHARES,"  and  together  with the Initial  Conversion  Shares,  the  "CONVERSION
SHARES").  Pursuant to the Purchase Agreement, the Company also has entered into
a  Registration  Rights  Agreement  with the Holders (the  "REGISTRATION  RIGHTS
AGREEMENT")  pursuant  to which the  Company  agreed,  among  other  things,  to
register  the  resale  of  the   Registrable   Securities  (as  defined  in  the
Registration  Rights  Agreement),  including the shares of Common Stock issuable
upon conversion of the Preferred  Shares and Additional  Investment Right Shares
and upon exercise of the Warrants  under the  Securities Act of 1933, as amended
(the  "1933  ACT").  In  connection  with the  Company's  obligations  under the
Registration  Rights  Agreement,  on ____________ ___, 2004, the Company filed a
Registration   Statement  on  Form  SB-2  (File  No.   333-_____________)   (the
"REGISTRATION  STATEMENT")  with the  Securities  and Exchange  Commission  (the
"SEC") relating to the Registrable Securities which names each of the Holders as
a selling stockholder thereunder.

      In connection with the foregoing, we advise you that a member of the SEC's
staff has advised us by  telephone  that the SEC has entered an order  declaring
the  Registration  Statement  effective  under  the 1933 Act at  [ENTER  TIME OF
EFFECTIVENESS] on [ENTER DATE OF EFFECTIVENESS] and we have no knowledge,  after
telephonic  inquiry  of a  member  of the  SEC's  staff,  that  any  stop  order
suspending its  effectiveness  has been issued or that any  proceedings for that
purpose  are  pending  before,  or  threatened  by, the SEC and the  Registrable
Securities  are  available  for  resale  under  the  1933  Act  pursuant  to the
Registration Statement.

<PAGE>

      This letter shall serve as our standing  opinion to you that the shares of
Common Stock are freely transferable by the Holders pursuant to the Registration
Statement.  You need not require  further  letters  from us to effect any future
legend-free  issuance or  reissuance of shares of Common Stock to the Holders as
contemplated  by the Company's  Irrevocable  Transfer Agent  Instructions  dated
August __, 2004.  This letter shall serve as our  standing  instructions  to you
with regard to this matter.

                                            Very truly yours,

                                            [ISSUER'S COUNSEL]

                                            By:_____________________

CC:      [LIST NAMES OF HOLDERS]

<PAGE>

                                                                       EXHIBIT B

                              SELLING STOCKHOLDERS

      The shares of common stock being offered by the selling  stockholders  are
issuable (i) upon conversion of the preferred  shares and additional  investment
right shares  issuable upon exercise of  additional  investment  rights and (ii)
upon  exercise  of  the  warrants.  For  additional  information  regarding  the
preferred  shares,  additional  investment  rights and  warrants,  see  "Private
Placement of Preferred Shares, Additional Investment Rights and Warrants" above.
We are  registering  the shares of common  stock in order to permit the  selling
stockholders  to offer the shares for resale  from time to time.  Except for the
ownership  of  the  preferred  shares,  additional  investment  rights  and  the
warrants,  the selling stockholders have not had any material  relationship with
us within the past three years.

      The table  below  lists the  selling  stockholders  and other  information
regarding the beneficial  ownership of the shares of common stock by each of the
selling  stockholders.  The second  column  lists the number of shares of common
stock beneficially owned by each selling stockholder,  based on its ownership of
the preferred  shares,  additional  investment  rights and the  warrants,  as of
________,  2004,  assuming conversion of all the preferred shares and additional
investment  right shares and exercise of all  additional  investment  rights and
warrants held by the selling  stockholders  on that date,  without regard to any
limitations on conversions or exercise.

      The third column  lists the shares of common  stock being  offered by this
prospectus by the selling stockholders.

      In accordance  with the terms of registration  rights  agreements with the
holders of the preferred  shares and the  warrants,  this  prospectus  generally
covers  the  resale  of at least  the sum of (i) 130% of the  maximum  number of
shares of common stock  issuable upon  conversion  of the  preferred  shares and
additional  investment  right shares  (assuming  that the  preferred  shares are
convertible  at their initial  Conversion  Price and without taking into account
any  limitations  on the  conversion  of the  preferred  shares set forth in the
Certificate  for the  preferred  shares) and (ii) 130% of the maximum  number of
shares of common stock issuable upon exercise of the related  warrants  (without
taking into account any limitations on the exercise of the warrants set forth in
the warrants), in each case as of the trading day immediately preceding the date
this  registration  statement  was  initially  filed with the SEC.  Because  the
conversion  price of the preferred shares and the exercise price of the warrants
may be adjusted,  the number of shares that will  actually be issued may be more
or less than the number of shares being offered by this  prospectus.  The fourth
column assumes the sale of all of the shares offered by the selling stockholders
pursuant to this prospectus.

      Under the terms of the preferred shares, the additional  investment rights
and the warrants,  a selling stockholder may not convert the preferred shares or
additional investment right shares, or exercise the warrants, to the extent such
conversion or exercise would cause such selling  stockholder,  together with its
affiliates,  to beneficially  own a number of shares of common stock which would
exceed  9.99% of our then  outstanding  shares of common  stock  following  such
conversion or exercise,  excluding for purposes of such determination  shares of
common stock  issuable upon  conversion  of the  preferred  shares or additional
investment  right shares which have not been  converted and upon exercise of the
warrants  which  have not been  exercised.  The  number of shares in the  second
column does not reflect this limitation.  The selling stockholders may sell all,
some or none of their shares in this offering. See "Plan of Distribution."

<PAGE>

<TABLE>
<CAPTION>
                                                                    MAXIMUM NUMBER OF SHARES
                                          NUMBER OF SHARES OWNED     TO BE SOLD PURSUANT TO      NUMBER OF SHARES
NAME OF SELLING STOCKHOLDER                  PRIOR TO OFFERING           THIS PROSPECTUS        OWNED AFTER OFFERING
---------------------------                  -----------------           ---------------        --------------------
<S>                                       <C>                       <C>                         <C>
SMITHFIELD FIDUCIARY LLC (1)                                                                             0
BRISTOL CAPITAL ADVISORS, LLC (2)
CALDWELL, DEREK
CRANSHIRE CAPITAL LP (3)
CRESTVIEW CAPITAL FUNDS (4)

DKR OASIS (5)
IROQUOIS CAPITAL (6)
LACHMAN, RON
</TABLE>

      (1) Highbridge  Capital  Management,  LLC  ("HIGHBRIDGE"),  is the trading
manager of Smithfield  Fiduciary LLC  ("SMITHFIELD") and consequently has voting
control and investment  discretion  over the ordinary shares held by Smithfield.
Glenn Dubin and Henry Swieca control Highbridge.  Each of Highbridge and Messrs.
Dubin  and  Swieca  disclaims   beneficial  ownership  of  the  shares  held  by
Smithfield.

      (2)

      (3) Mitchell P. Kopin is the  president of Downsview  Capital,  Inc.,  the
general  partner of Cranshire  Capital,  L.P.,  and has sole voting  control and
investment discretion over securities held by Cranshire Capital, L.P.

      (4)

      (5)

      (6)

<PAGE>

                              PLAN OF DISTRIBUTION

      We are  registering the shares of common stock issuable upon conversion of
the preferred shares and additional investment right shares and upon exercise of
the warrants to permit the resale of these shares of common stock by the holders
of the preferred shares, the additional  investment rights and the warrants from
time to time after the date of this  prospectus.  We will not receive any of the
proceeds  from the sale by the  selling  stockholders  of the  shares  of common
stock. We will bear all fees and expenses incident to our obligation to register
the shares of common stock.

      The selling stockholders may sell all or a portion of the shares of common
stock  beneficially  owned by them and offered hereby from time to time directly
or through one or more underwriters,  broker-dealers or agents. If the shares of
common  stock are sold  through  underwriters  or  broker-dealers,  the  selling
stockholders  will be responsible for  underwriting  discounts or commissions or
agent's  commissions.  The  shares  of  common  stock may be sold in one or more
transactions  at fixed prices,  at  prevailing  market prices at the time of the
sale, at varying prices determined at the time of sale, or at negotiated prices.
These sales may be effected in transactions,  which may involve crosses or block
transactions,

      o     on any national  securities  exchange or quotation  service on which
            the securities may be listed or quoted at the time of sale;

      o     in the over-the-counter market;

      o     in  transactions  otherwise than on these exchanges or systems or in
            the over-the-counter market;

      o     through the writing of options,  whether  such options are listed on
            an options exchange or otherwise;

      o     ordinary  brokerage  transactions  and  transactions  in  which  the
            broker-dealer solicits purchasers;

      o     block  trades in which the  broker-dealer  will  attempt to sell the
            shares as agent but may  position  and resell a portion of the block
            as principal to facilitate the transaction;

      o     purchases  by  a  broker-dealer  as  principal  and  resale  by  the
            broker-dealer for its account;

      o     an  exchange  distribution  in  accordance  with  the  rules  of the
            applicable exchange;

      o     privately negotiated transactions;

      o     short sales;

      o     pursuant to Rule 144 under the Securities Act;

      o     broker-dealers may agree with the selling  securityholders to sell a
            specified number of such shares at a stipulated price per share;

<PAGE>

      o     a combination of any such methods of sale; and

      o     any other method permitted pursuant to applicable law.

      If the selling  stockholders effect such transactions by selling shares of
common  stock  to  or  through  underwriters,  broker-dealers  or  agents,  such
underwriters,  broker-dealers  or agents may receive  commissions in the form of
discounts,   concessions  or  commissions  from  the  selling   stockholders  or
commissions  from purchasers of the shares of common stock for whom they may act
as agent or to whom they may sell as principal (which discounts,  concessions or
commissions as to particular  underwriters,  broker-dealers  or agents may be in
excess of those customary in the types of transactions  involved). In connection
with sales of the shares of common stock or otherwise,  the selling stockholders
may enter  into  hedging  transactions  with  broker-dealers,  which may in turn
engage in short sales of the shares of common  stock in the course of hedging in
positions they assume.  The selling  stockholders may also sell shares of common
stock short and deliver  shares of common stock  covered by this  prospectus  to
close out short  positions.  The  selling  stockholders  may also loan or pledge
shares of common stock to broker-dealers that in turn may sell such shares.

      The selling  stockholders may pledge or grant a security  interest in some
or all of the preferred shares, warrants or shares of common stock owned by them
and,  if they  default in the  performance  of their  secured  obligations,  the
pledgees or secured  parties may offer and sell the shares of common  stock from
time to time pursuant to this  prospectus  or any  amendment to this  prospectus
under Rule  424(b)(3) or other  applicable  provision of the  Securities  Act of
1933, as amended,  amending,  if necessary,  the list of selling stockholders to
include  the  pledgee,  transferee  or other  successors  in interest as selling
stockholders under this prospectus.  The selling  stockholders also may transfer
and donate the shares of common stock in other  circumstances  in which case the
transferees,  donees,  pledgees  or other  successors  in  interest  will be the
selling beneficial owners for purposes of this prospectus.

      The  selling  stockholders  and  any  broker-dealer  participating  in the
distribution  of the shares of common  stock may be deemed to be  "underwriters"
within the  meaning of the  Securities  Act,  and any  commission  paid,  or any
discounts or concessions  allowed to, any such broker-dealer may be deemed to be
underwriting  commissions or discounts  under the Securities  Act. At the time a
particular  offering  of the  shares  of  common  stock  is made,  a  prospectus
supplement,  if required, will be distributed which will set forth the aggregate
amount of shares of common  stock being  offered and the terms of the  offering,
including  the name or names of any  broker-dealers  or agents,  any  discounts,
commissions  and  other  terms   constituting   compensation  from  the  selling
stockholders and any discounts,  commissions or concessions allowed or reallowed
or paid to broker-dealers.

      Under the securities  laws of some states,  the shares of common stock may
be sold in such states only through  registered or licensed  brokers or dealers.
In  addition,  in some states the shares of common  stock may not be sold unless
such  shares  have been  registered  or  qualified  for sale in such state or an
exemption from registration or qualification is available and is complied with.

<PAGE>

      There can be no assurance  that any selling  stockholder  will sell any or
all of the shares of common stock registered  pursuant to the shelf registration
statement, of which this prospectus forms a part.

      The  selling  stockholders  and any  other  person  participating  in such
distribution will be subject to applicable provisions of the Securities Exchange
Act of 1934, as amended,  and the rules and regulations  thereunder,  including,
without limitation, Regulation M of the Exchange Act, which may limit the timing
of  purchases  and sales of any of the  shares of  common  stock by the  selling
stockholders and any other participating person.  Regulation M may also restrict
the ability of any person  engaged in the  distribution  of the shares of common
stock to engage in market-making activities with respect to the shares of common
stock. All of the foregoing may affect the marketability of the shares of common
stock and the  ability  of any  person  or  entity  to  engage in  market-making
activities with respect to the shares of common stock.

      We will pay all expenses of the registration of the shares of common stock
pursuant to the registration  rights  agreement,  estimated to be $[ ] in total,
including,  without  limitation,  Securities and Exchange Commission filing fees
and expenses of compliance with state  securities or "blue sky" laws;  provided,
however,  that a selling  stockholder  will pay all  underwriting  discounts and
selling commissions,  if any. We will indemnify the selling stockholders against
liabilities,  including some liabilities under the Securities Act, in accordance
with the registration  rights  agreements,  or the selling  stockholders will be
entitled to  contribution.  We may be  indemnified  by the selling  stockholders
against civil liabilities,  including liabilities under the Securities Act, that
may  arise  from  any  written  information  furnished  to  us  by  the  selling
stockholder  specifically  for use in this  prospectus,  in accordance  with the
related registration rights agreements, or we may be entitled to contribution.

Once sold under the shelf registration statement, of which this prospectus forms
a part,  the  shares of common  stock  will be freely  tradable  in the hands of
persons other than our affiliates.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]